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ABSTRACT
PEDIATRIC BRAIN TUMORS AND SUBSEQUENT COMMUNICATION AND
SWALLOWING DISORDERS
(Under the direction of Dr. Carolyn Wiles Higdon)
This study was designed to determine if there were speech, language, or swallowing
disorders in a child with a brain stem glioma tumor or medulloblastoma tumor. It
also was designed to determine if motor speech was more affected than swallowing in
a child with a brain stem glioma tumor and in a child with a medulloblastoma tumor.
Thirdly, this study investigated the incidence and treatment of speech, language, or
swallowing disorders through survey. The surveys were sent through the United
States Postal Service to speech-language pathologists (SLPs). The SLPs worked in
pediatric hospitals or hospitals with pediatric floors. The purpose of the surveys was
to gain information regarding the SLPs’ perceptions regarding prevalence of
communication and/or swallowing disorders and type and duration of communication
and/or swallowing disorders found following medical management. The researcher’s
first hypothesis was that there were no diagnosed disorders of speech, language
and/or swallowing in a child with a brain stem glioma tumor or medulloblastoma
tumor. The researcher’s second hypothesis was that swallowing disorders were the
primary communicative disorders identified and treated by SLPs in a child with a
brain stem glioma tumor or medulloblastoma tumor. The results of this study showed
the first hypothesis to be rejected due to the identification of speech, language and/or
swallowing disorders in children with the two types of tumors. The results of this
study also showed no significant difference between the number of SLPs who
identified swallowing disorders and the number of SLPs who identified motor speech
disorders in children with brain stem gliomas or medulloblastomas.
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CHAPTER ONE
INTRODUCTION
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CHAPTER ONE
INTRODUCTION
Brain tumors are the second most common form of pediatric cancer behind
leukemia, affecting between 1,500 and 2,000 children annually (Tomita, 2000). Such
tumors result from the abnormal growth of brain tissue. Some common types of
pediatric brain tumors, or neoplasms, are astrocytomas, medulloblastomas, or
ependymomas (see Appendix H for a list of definitions). Astrocytomas are central
nervous system (CNS, Appendix G)neoplasms derived from astrocytes, which are
cells found between blood vessels and neurons (Greenberg, 1997). The term
medulloblastoma" describes a series of tumors found in the cerebellum of a child’s
brain (Bailey & Cushing, 1925). An ependymoma is a type of glioma that comes
from ependymal cells, which are cells that line the ventricles within the brain and the
center of the spinal cord (Capodano, 2001).
Children diagnosed with brain tumors have symptoms of headaches, blurred
vision, drowsiness, weakness in their limbs, balance problems and impaired speech.
These children also may have seizures, vomit suddenly, exhibit changes in behavior.
and exhibit an increase in head size. Brain tumors are classified according to their
size, location, and cell origin. Treatment for most tumors may include chemotherapy.

radiation therapy and/or surgery. Children often require extensive rehabilitation
following medical treatment. This may include speech-language therapy, physical
therapy, and occupational therapy to address resultant problems in communication.
motor activities and activities of daily living (ADLs), as well as cognitive and
educational therapy.
Physicians diagnose brain tumors through the use of computed tomography
(CT)scans, which were developed in the mid-1970s (Tomita, 2000). These CT scans
show the skull framework, and presence of blood clots and tumors. CT scans allow
physicians to obtain a more comprehensive understanding of the pathological changes
that may have occurred due to the blood clots or tumors. Tumors appear white, while
the rest of the brain appears grey, helping physicians’ identification. Also,
cerebrospinal fluid (CSF), fat, and air appear black on CT scans helping to identify
pathological changes (Tomita, 2000). Possible changes could include hydrocephalus.
brain edema, hemorrhages, cysts, or calcifications. Physicians also use magnetic
resonance imaging(MRI)to identify brain tumors. MRIs, introduced in the 1980s,
give a three-dimensional image that is clearer and crisper than CT scans by
combining high-frequency radio waves and a strong magnetic field to produce an
image of the inside of the brain (Jallo & Epstein, 2004). Magnetic resonance
angiography(MRA)provides information on the vascularity of the tumor, and
magnetic resonance spectroscopy(MRS)provides information on the chemical make¬
up of the tumor to differentiate tumors from other growths (Tomita, 2000).
Medical treatment options for pediatric brain tumors include chemotherapy.
radiation and surgery (Packer, 1999). Chemotherapy attempts to inhibit cell growth
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and metabolism so that the mutant cells will not continue to reproduce, and therefore
the tumor will not grow (Rood, n. d.). Each type of chemotherapy drug affects cells
in a different way; therefore multiple chemotherapy drugs are used in treatment. The
problem with chemotherapy is that the drugs affect not only just the cancer cells, but
also the healthy cells, which weakens the child’s immune system. For brain
neoplasms, chemotherapy can be administered through the carotid artery (intra
arterial) or directly to the CSF (intrathecal)(Rood, n. d.). Intra-arterial chemotherapy
is given to either side of the posterior fossa, and the circulation delivers a high
concentration to the intended area. Intrathecal chemotherapy is given directly to the
CSF space and along the CSF pathway. This type of chemotherapy delivers a higher
concentration to the tumor cells lurking in the CSF pathway. Intrathecal
chemotherapy can be administered via spinal taps or catheter. Physicians choose and
change the chemotherapy protocol (whether intra-arterial or intrathecal) based on the
child’s type of tumor and his/her response to previous treatment.(Rood, n. d.)
Physicians use radiation therapy for children with malignant brain tumors or
Linresectable benign brain tumors in order to hopefully eradicate the microscopic cells
that may have escaped surgery. These residual tumor cells are the main cause of
recurrent tumors. High energy rays infiltrate the dermis and internal skull structures
during external beam radiation therapy (EBRT), where the beam is directed from an
outside source such as a linear accelerator (Black, 2006) and exposes everything in
the radiation’s path (Tomita, 2000). As a result, EBRT may also affect hair cells and
bone maiTow which may cause children to lose their hair and to have a decreased
number of white blood cells, platelets, and red blood cells. EBRT may also affect the

4

endocrine organs, pituitary gland function, thyroid gland function and blood vessels.
Internal radiation therapy (IRT), as opposed to the EBRT, involves surgeons inserting
a catheter containing small radioactive seeds in the tumor. The surgeon then removes
the seeds after the prescribed dose of radiation is delivered (Tomita, 2000). This
procedure administers the radiation just to a single area reducing the risk of exposing
healthy brain tissue to high doses of radiation (Merchant, 2008). Intellectual deficits
resulting from secondary effects of radiation therapy are a concern (Spiegler, Bouffet,
Greenberg, Rutka & Mabbott, 2004).
Surgery is the primary treatment of pediatric brain tumors, especially benign
tumors. Even when total resection is not possible, surgery may be beneficial to
children with large, malignant tumors by removing as much of the tumor as possible.
allowing chemotherapy and/or radiation therapy to have a stronger effect. As
technology improves, surgical resection techniques improve giving surgeons the
means to completely remove brain tumors (Stargatt, Rosenfeld, Maixner & Ashley,
2007). Preoperative CT scans and MRI images guide the neurosurgeon to the exact
location of the tumor during surgery, greatly increasing the surgeons’ ability to find
and remove the tumor. Tumors invading the brain stem, diencephalons, or optic
chiasm, however, are unresectable, but they may be operable (see Appendix I for
diagrams of the brain). Surgical complications that may occur include hemorrhaging,
swelling in the cranial cavity, infection, and neurological deficits. These
complications are also possible precursors to speech, language, hearing, and
swallowing issues.(Tomita, 2000)
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In this thesis, the main tumors considered are medulloblastoma tumors and
brain stem glioma tumors. These tumors were chosen for the study because they both
originate in the posterior fossa portion of the brain and are two of the most common
brain tumors in children. A medulloblastoma tumor is one type of malignant brain
tumor that arises in the fourth ventricle and cerebellar vermis, or the posterior fossa
region of the brain (Stargatt, et. al., 2007). Scientists believe these tumors originate
from the posterior medullary velum, but the exact cellular origin is still unknown.
These tumors account for 20% of childhood brain tumors, and 15% of
medulloblastomas occur in the cerebellar hemisphere (Gajjar & Doyle, n.d.). In most
cases these tumors occur in the first ten years of a child’s life with 50% occurring in
the first five or six years (Disease Information, Medulloblastoma/PNET, n. d.).
Children usually have headaches and vomiting, and may also appear clumsy
exhibiting problems with motor tasks such as handwriting, with symptoms worsening
over time. If the tumor has spread to the spinal cord region, children may experience
back pain, problems with walking, and/or lose control of their bladder. Physicians
most often treat medulloblastoma tumors with surgery, radiation, and/or
chemotherapy. Individuals with medulloblastoma neoplasms have a high survival
rate(60% to 80%)due to surgeons’ ability to remove a majority of the tumor during
initial surgery and due to the rehabilitative therapies following surgery. Children also
must undergo postoperative radiation and chemotherapy in order to ensure there are
no cancerous cells still lurking in the brain.(Tomita, 2000)
Brain stem glioma tumors are tumors that arise along the midbrain, pons, or
medulla, deep in the posterior portion of the brain with a majority of brain stem
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glioma tumors occurring in the pons. These brain stem tumors account for 25% to
30% of childhood brain neoplasms and most often occur in children between the ages
of five and ten years old (Al-Shatoury, Galhom & Engelhard III, n. d.). Pontine brain
stem gliomas, in particular, affect the cranial nerves causing abducens nerve and
facial nerve palsy, dysarthria, ataxia, and hemiparesis (Tomita, 2000). Abducens
palsy affects the sixth cranial nerve, which controls eye movements (Ehrenhaus &
Hajee, 2006). Surgery is not usually a viable option for brain stem gliomas because
these tumors entrench themselves over too large an area of the brain stem making
complete removal of the tumor difficult. Surgery, however, may be an option for
localized brain stem gliomas because it can be used to remove parts of the tumor
(Disease Information, Brain Stem Glioma, n. d.). Radiation and chemotherapy are
introduced to reduce the growth of a brain stem glioma tumor, with radiation therapy.
usually being the initial choice for treatment(Disease Information, Brain Stem
Glioma, n. d.). Children with pontine gliomas rarely survive 12 or 14 months post
diagnosis, but children with a midbrain or medullary glioma have a 65% to 90%
chance of survival (Tomita, 2000).
The incidence of pediatric brain tumors has increased from 2.5 to 4 per
100,000 per year (Packer, 1999) to 4.5 per 100,000 per year(CBTRUS, 2007-2008).
This number has risen not only due to improved diagnostic methods and increased
awareness, but also due to environmental factors (Tomita, 2000). The following
statistics are according to the 2007-2008 Central Brain Tumor Registry of the United
States(CBTRUS). Every day nine more children in the United States are diagnosed
with a brain tumor, and there are over 120 types of brain tumors. Only sixty-six
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percent of children diagnosed with brain tumors survive more than five years.
Survival rate has improved only slightly over the past few years, a fact supporting the
need for an increase in research on pediatric brain neoplasms. Researchers are
currently striving to understand the changes that can occur in tumor cells to create
cancer (Tomita, 2000). Scientists believe that studying the genetic characteristics of
these cells will help identify tumors requiring particular types of treatment. Radiation
oncologists are investigating how to provide radiation therapy in a manner that will
lessen the damage to normal brain cells (Disease Information, Brain Stem Glioma, n.
d.). Scientists at St. Jude Children’s Research Hospital,(www.stjude.org), are also
conducting stem cell research to develop new ways to use high-dose chemotherapy.
They are also testing using more intensive chemotherapy on children with low-risk
and high-risk tumors (Disease Information, Medulloblastoma/PNET, n. d.).
Specifically for medulloblastoma tumors, much research is being directed toward
finding ways to reduce the intelligent quotient(IQ)loss which often occurs post¬
treatment (Disease Information, Medulloblastoma/PNET, n. d.). Scientists are
studying new drugs for brain stem neoplasms which will enhance radiation therapy
and as well as new radiation techniques which provide for more localized therapy
(Tomita, 2000).
The author of this study is familiar with the great strides in cancer research
made by St. Jude Children’s Research Hospital’s (Memphis, Tennessee). The author
developed an interest in the role of the speech language pathologist(SLP) in the
management of children diagnosed with pediatric tumors, after volunteering at the
Ronald McDonald House and Target House, which house families of patients being
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treated at St. Jude Children’s Research Hospital. Personal appreciation of the
devastating effects that a speech, hearing, and/or swallowing problem resulting from
treatment for a brain tumor creates for families led to this research project.
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CHAPTER TWO
LITERATURE REVIEW
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CHAPTER TWO
LITERATURE REVIEW
Research on pediatric brain tumors covers many aspects, such as the causes of
tumors, differences between the tumors, primary and secondary effects of the tumors.
treatments for tumors, and different surgical strategies. Although some tumors are
considered treatable in children, many are not treatable. The growth of these tumors
may be slowed down, but they are often unresectable (Tomita, 2000). Tumors
considered unresectable, yet operable, are those entrenched in the brain stem.
diencephalons, or optic chiasm (Tomita, 2000). The prescribed course of treatment
depends on the size and location of the tumor, and the prognosis given by the
physician (Packer, 1999). Physicians also consider the possible side effects of
treatment and how these side effects may affect the child’s daily life (Packer, 1999).
Researchers are investigating these side effects as well as treatment options in hopes
of increasing survival rates and improving the children’s quality of life.
The purpose of this literature review is to give the reader general information
about pediatric brain tumors, to identify research concerning both brain stem gliomas
and medulloblastomas (the two tumors studied in this thesis), to give information
about speech and language disorders occurring as a result of the brain tumors, to
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explore posterior fossa syndrome and to consider whether oral and pharyngeal
dysphagia may occur as a result of these two pediatric brain tumors. The literature is
divided into five sections: general information, information on brain stem gliomas,
information on medulloblastomas, information on speech, language and/or
swallowing disorders that may occur as a result of the tumor and/or treatment, and
information on posterior fossa syndrome.
General Information
There are 1,200 to 1,500 children under 16 years of age diagnosed with brain
tumors yearly (Robertson, 1998). Carpentieri, Waber, Pomeroy, Scott, Goumnerova,
Kieran, Billett, and Tarbell (2003) claimed that because the treatment of brain tumors
has advanced and survival and cure rates have increased, the quality of life issues.
including neuropsychological outcomes, have greater relevance. Thus, identification
of factors associated with the tumors and medical treatments that can affect the
outcome of the rehabilitative treatments is extremely important.
Sala, Colarusso, Mazza, Talacchi, and Bricolo (1999)studied brain tumors in
children under the age of three years after the introduction of magnetic resonance
imaging (MRIs). Their research indicated that the incidence of brain tumors in
children under the age of three has increased because of the introduction of MRIs, but
that the risk factors (including sex, age, duration of symptoms, intracranial
hypertension on admission, tumor location, surgical removal, and histology) have not
been completely identified. The most common symptoms of these tumors were
vomiting, delayed development, increase in head circumference, lethargy, irritability.
and motor deficits. The majority of early childhood brain tumors identified in Sala,
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et. al.'s study (1999) occurred in midline structures in the brain, especially the fourth
ventricle and the hypothalamus region. These tumors were referred to as low-grade
tumors, which are more localized and grow slower (Disease Information,
Astrocytoma/Glioma, n. d.).
Poggi, Liscio, Galbiati, Adduci, Massimino, Gandola, Spreafico, Clerici,
Fossati-Bellani, Sommovigo, and Castelli(2004) researched general cognitive and
psychological disorders as a result of brain tumors in children and adolescents.
Discrete lesions in the cerebellar vermis and deep nuclei can have profound effects on
cognitive functions and often are reasons for some cognitive disorders following
treatment of pediatric brain tumors(Wisoff & Epstein, 1984, Humphreys, 1989,
Pollack, Polinko, Albright, Towbin,& Fitz, 1995). Cognitive and psychological
disorders comprised the most frequently observed pathological conditions following
pediatric and adolescent brain tumors. A reason, according to Stargatt, Rosenfeld,
Maixner, and Ashley (2007), is because there is a range of tumor and treatment
complications. The exploration of psychological disorders resulting from tumor
growth has been scarce, with the main focus directed to diagnosis and treatment of
resulting motor and sensory disorders. An overall decrease in children’s intelligent
quotient(IQ)scores was reported during neuropsychological studies, and the main
risk factors appeared to be age, site of lesion, infections, treatment regimen, and
increase in intracranial pressure. The primary psychological problems, according to
the Child Behavior Check List(CBCL)(Achenbach & Edelbrock, 1983), were
withdrawal(22.6% of the population studied), decrease in social skills (22.6% ot the
population studied), and internalizing problems (48.4% of the population studied).
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All three test groups were impaired cognitively, but the oldest children in the study
were more cognitively impaired. Researchers found a parallel between cognitive and
psychological disorders as a result of a brain tumor. The cognitive disorders
identified appeared to cause more learning difficulties and then indirectly create the
psychological disorders (Poggi, et. al., 2004).
Brain Stem Gliomas
Over one-half of all pediatric brain tumors are glial tumors. Low-grade glial
tumors occur in the posterior fossa and diencephalic region (Packer, 1999). More
than 90% of these children die within 18 months of diagnosis, because of the speed
and progressive nature of these tumors. One notable advancement, however, is the
understanding that not all brain stem tumors are diffuse intrinsic brain stem glioma
tumors. Twenty percent(20%) will be more focal lesions, which are usually
astrocytomas, and have a more favorable prognosis in terms of survival. Surgery for
brain stem gliomas may help control the growth and prolong life for a time, but may
also cause neurological impairments. Chemotherapy or radiation may result in more
long-term disease control, and less neurological impairments (Packer, 1999).
Benesch, Lackner, Moser, Kerbl, Schwinger, Oberbauer, Eder, Mayer,
Wiegele, and Urban (2001) explored the long-term effects of radiochemotherapy for
pediatric brain stem gliomas. The children were given simultaneous
radiochemotherapy during the first cycle of chemotherapy. Doctors found
neurological deficits in all children after diagnosis of the brain tumor, but no increase
in these deficits after neurorehabilitation. The median survival rate for children with
brain stem gliomas was less than one year, according to Benesch et aPs study.
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Researchers found, in most cases, that the long-term survival rate was just as high in
patients treated only with radiation as those treated only with chemotherapy.
Medulloblastomas
Medulloblastomas were the other type of pediatric brain tumor researched
throughout this literature review. Many medulloblastoma tumors arise from the
cerebellum and surrounding structures (Stargatt, et. al., 2007). According to
Schmahmann and Pandya (1997), the cerebellum is strongly interconnected with the
cerebral hemispheres in both feed-forward and feed-back directions. Because of this
fact, researchers suggested the cerebellum could play a role in higher cortical
functions, such as attention regulation and information processing (Stargatt, et. al..
2007). Such observations are important for children with posterior fossa tumors
because of the link between cerebellar damage and long-term cognitive disorders.
Researchers have observed cognitive disorders in this population (Beebe, Ris, &
Holmes, 2001; Copeland, De Moor, Moore, & Ater, 1999; Karatekin, Lazareff, &
Asamow,2000; Le Barro, Zeltzer, Zeltzer, Scott, & Martin, 1988; Levisohn, CroninGolomb,& Schmahmann, 2000; Palmer, Gajjar, Reddick, Glass, Kun, Wu,et. al.,
2003; Riva & Giorgi, 2000; Riva, Panelaeoni, Milani, & Fossati, 1989; Scott,
Stoodley, Anslow, Paul, Stein, Sugden, et. al., 2001). One complication of
medulloblastoma resection surgery (surgery to excise the tumor) is hydrocephalus
(Jacobs, Northam,& Anderson, 2001; Stargatt, et. al., 2007). Hydrocephalus
significantly impacts cognitive development in children with brain tumors (Anderson
& Taylor, 1999; Anderson, Northam, Hendy,& Wrennall, 2001; Jacobs, et. al..
2001), especially in information and attention processing, and memory, language and
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executive deficits (Anderson et al, 2001). Postoperative cerebellar mutism syndrome
(CMS)and posterior fossa syndrome were observed in many children with
medulloblastoma tumors following medical treatment.
Speech-Language Disorders after Brain Tumors
Goncalves, Radzinsky, da Silva, Chiari, and Consonni(2006)observed the
speech, language, and hearing development of children with brain tumors. The
speech-language pathologists (SLPs)evaluated the children, through clinical protocol.
in the areas of swallowing, voice, speech, oro-facial evaluations, language, and
hearing development to identify the primary communication and swallowing
disorders. Most of the children(41%)complained of swallowing disorders over
speech or language disorders (29%), but 81% of the children were diagnosed with a
speech, language, and/or hearing disorder. Testing revealed additional disorders,
including dysphonia (14%), which is a phonation disorder characterized by breathy
voice quality, hearing problems(9%), and facial palsy(6%). The results of the study
reinforced the presence of speech, language, hearing, and swallowing disorders in
children with these particular brain tumors.
Levisohn, Cronin-Golomb, and Schmahmann (2001) studied the
neuropsychological consequences of cerebellar tumor resection in children. The
children in their study did not receive radiation or types of chemotherapy drugs that
were shown to have cognitive or behavioral effects. The researchers found these
children had impairments in a) planning, sequencing and visual-spatial functions, b)
expressive language, c) verbal memory, and d) modulation of affect. In combination.
these deficits form the characteristics of cerebellar cognitive affective syndrome. The
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children were tested with a battery of neuropsychological tests, to include the
Wechsler Preschool and Primary Scales ofIntelligence(WPPSI-R)(Wechsler, 1989),
Differential Abilities Scale(DAS)(Elliott, 1990), Naming Vocabulary(McGrew &
Flanagan, 1998), Logical Memory Passagesfor Children (y^QchsX^v, 1945), Beery
Visual Motor Integration (VMI)(Beery, Buktenica, & Beery, 2006) and the Gardner
Expressive One-Word Picture Vocabulary Test(EOWPVT-R)(Gardner, 1990), pre
and post surgery. Physicians considered these children to have a deficit in cognitive
or behavioral effects if they noticed a persistent, postoperative change. Thirty-four of
the children evaluated in this study were diagnosed with medulloblastomas. Most of
the 34 children in this study exhibited visual-spatial difficulties, deficits in expressive
language, deficits in memory, and affective changes.
Docking, Ward, and Murdoch (2005) studied the language outcomes as a
result of brain stem tumor treatment in children. Four of the children were diagnosed
with low-grade astrocytomas, one child was diagnosed with an ependymoma, and one
child was diagnosed with a brain stem glioma. Previous research stated that
transitory mutism and dysarthria were related to the removal of midline cerebellar
tumors (Lalonde & Botez-Marquard, 2000). Docking, et. al.(2005) evaluated the
children in the areas of general language and high-level language/phonological
awareness using several tests which are listed in Table 2.1 below.

Test Name
Clinical Evaluation of
Language Fundamentals-Third
Edition (CELF-3)
Clinical Evaluation of
Language FundamentalsPreschool(CELF-P)

Test Purpose
General Language
Assessment
General Language
Assessment
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Author
Semel, Wiig, & Secord

Year
1995

Wiig & Secord

1992

Peabody Picture Vocabulary
Test-Third Edition (PPVT-III)
Hundred Pictures Naming Test
(HPNT)

General Language
Assessment

Dunn & Dunn

1997

General Language
Assessment

Fisher & Glenister

1992

Test of Problem SolvingElementary, Revised (TOPSElementary)
Test of Problem SolvingAdolescent (TOPS-Adolescent)

High Level
Language

Zachman, Huisingh,
Barrett, Orman,&
LoGiudice

1994

High Level
Language

1991

Test of Word Knowledge
(TOWK)
Test of Language CompetenceExpanded Edition (TLC-E)
Queensland University
Inventory of Literacy(QUIL)

High Level
Language
High Level
Language
Phonological
Assessment

Zachman, Berrett,
Huisingh, Orman,&
Blagden
Wiig & Secord

1992

Wiig & Secord

1989

Dodd, Holm,
Oerlemans, &
McCormick

1996

Test of Phonological
Phonological
Torgesen & Bryant
Assessment
Awareness(TOPA)
Table 2.1. Communication Tests Administered in the Docking et al Research

1994

Researchers did not find a significant difference between the general language
abilities and high-level language abilities in children treated for brain tumors and
children who did not have a brain tumor.
Research has also shown that cranial radiation therapy is associated with
adverse neuropsychological sequelae (abnormal conditions resulting from a previous
disease) in all children treated for cancer (Anderson, Smibert, Ekert, & Godber, 1994;
Cousens, Waters, Said, & Stevens, 1988; Heideman, Packer, Albright, Freeman, &
Rorke, 1997; Packer, Sutton, Atkins, Radclif, Bunin, D’angio, et. al., 1989). Short
term memory, attention and cognitive processing in general were reported to be
affected (Pfefferbaum-Levine, Copeland, Fletcher, Reid, Jaffe, & McKinnon, 1984).
The results of earlier studies (Hoppe-Hirsch, Renier, Lelliuch-Tubiana, Sainte-Rosen,
& Pierre-Kahn, 1990) showed a decline in IQ that progressed over time, but
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evaluations of more recent treatment protocols showed a plateau of decline occurring
at six years post-treatment for younger children (Palmer, et. al., 2003).
Papazoglou, King, Morris, and Krawiecki(2008) studied the relationship
between adaptive functioning and cognitive abilities. They cited the fact that
“childhood brain tumor survivors continue to be vulnerable to altered cognitive.
social and behavioral functioning,” based on Aarsen, Van Dongen, Paquier, Van
Mourik, and Catsman-Berrevoets’ 2004 article, “Long-term Sequelae in Children
after Cerebellar Astrocytoma Surgery.” Papazoglou, et. al.(2008)cited the lack of
research done on the relationship between adaptive functioning and cognitive abilities
with the pediatric neurological population. The authors proposed that tumors in
different locations would lead to different types of cognitive disorders. These
cognitive disorders would then be a factor in the adaptive functioning outcomes.
Papazoglou, et. al.(2008) explained adaptive functioning as “assessing the ability of
people to take care of themselves and interact with and assist others at an ageappropriate level.” The authors then described the possible effects of tumor location,
stating that cerebellar tumors may particularly affect attention skills because of
proximity to the ascending reticular activating system and other subcortical and
cortical areas that control attention and arousal. Tumors growing in the third
ventricle were also included in this study because the third ventricle is the location of
the hypothalamus, thalamus, fornix, and basal forebrain. Research results have
confirmed memory disturbances in children treated for tumors in the third ventricle
(Micklewright, King, Morris, & Morris, 2007). The study was retrospective using 36
children who were treated for tumors in either the third ventricle or cerebellar regions.
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The patients were tested using the Vineland Adaptive Behavior Scales(VABS)
(Sparrow, Balia & Cicchetti, 1984) and the Rey Auditory Verbal Learning Test
(RAVLT)(Rey, 1958). The VABS provided data about each child’s communication,
daily living skills, and socialization. The RAVLT assessed auditory attention span
and verbal memory. The results suggested that “there are differential cognitive
predictors of adaptive functioning according to brain tumor location (Papazoglou, et.
al., 2008).
Gilmer Knight, Kraemer, and Neuwelt(2005)looked at the effect of
platinum-based chemotherapy, which used the platinum drugs cisplatin and
carboplatin, in children with brain tumors. A study was conducted using audiological
evaluations including otoscopy, frequency-specific auditory brain stem response.
conventional audiometry, conditioned play audiometry, visual reinforcement
audiometry, and pure tone audiometry, on 67 children from eight months to 23 years
old, who had received platinum-based chemotherapy. The platinum agents (cisplatin
and carboplatin) in the chemotherapy correlated with adverse effects such as
ototoxicity and permanent hearing loss (Blakeley & Myers, 1993; Brock, Bellman,
Yeomans, et. al., 1991; Li, Womer,& Silber, 2004; Ilveskoski, Saarinen, Wiklund, et.
al., 1998; Montaguti, Brandolini, Ferri, et. al., 2002; Skinner, Pearson, Amineddine,
et. al., 1990). Hearing loss that results from ototoxicity can be significant,
influencing speech and language development, educational achievement, and socialemotional development (Blair, Peterson, & Viehweg, 1985). The results of this study
stated that 61% of the children studied showed bilateral decreases in hearing. The
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children diagnosed with medulloblastoma tumors, osteosarcoma tumors, and
neuroblastoma tumors had a greater incidence and more severity of hearing loss.
Rekate. Grubb, Aram, et. al.(1985) were the first to describe cerebellar
mutism in children with cancer. For the purpose of their study cerebellar mutism was
defined as a “transient and not uncommon complication following surgical resection
of posterior fossa tumors.” Mutism after posterior fossa surgery in children included
the additional neurological deficits of ataxia, hemiparesis, cognitive deficits, cranial
nerve palsies, and bulbar palsy. Children with this type of mutism have good
comprehension, without evidence of oral apraxia before any type of surgical
intervention (Clerico, et. al., 2002).
Posterior Fossa Syndrome
Posterior fossa brain tumors account for 54% to 70% of all known pediatric
brain tumors according to Al-Shatoury, et. al.(2008). The most common types of
posterior fossa tumors are medulloblastomas, cerebellar astrocytomas, brain stem
gliomas, and ependymomas(Hudgins & Edwards 1987, Packer, et. al., 1987).
Doxey, Bruce, Sklar, Swift, & Shapiro(1999) researched the risk factors and
iiTeversible complications of posterior fossa syndrome. Physicians noticed this
syndrome, also referred to as cerebellar mutism, as a changeable condition that could
occur after posterior fossa surgery in children (Rekate, et. al., 1985). The condition
resolved in most cases after only a few days, but could persist for a year. The
researchers defined this type of mutism as “the inability to articulate single
monosyllabic words.”
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The study discussed 18 children, who were reported to have posterior fossa
syndrome 24 to 48 hours after surgery. One child was reported to have posterior
fossa syndrome four days post-surgery; another child developed posterior fossa
syndrome seven days post-surgery; and one child spoke immediately after surgery,
then demonstrated mutism within the next 24 hours. Once the children began to
regain their speech, their speech took on dysarthric characteristics then their speech
intelligibility improved in stages. Similarities among the children led the researchers
to believe that the location of the tumor contributed to the development of posterior
fossa syndrome. All children were diagnosed with tumors affecting the brain stem or
the middle cerebellar branch or both areas. Doxey, et. al.,(1999) believed other
factors, such as the piercing of the vermis during surgery, injury to the middle of the
cerebellum during surgery, and the involvement of the dentate nucleus, could
contribute to postoperative mutism in children. Levisohn, et. al.,(2000)found that
extensive vei*mis damage in children who underwent posterior fossa surgery led to
posterior fossa syndrome in five out of the nine cases studied.
Boghen and Aoichane(1991) described a case where the child lost reaction in
her pupils. This loss of pupillary reaction was probably a secondary effect of
aqueduct obstruction and ensuing hydrocephalus as well as functional interference
with visceral motor nuclei of the third nerve. According to Arthur Skarin in the
Journal of Clinical Oncology (2001), “these neurofunctional features can belong to
the posterior fossa syndrome, a complex cohort of signs and symptoms characterized
by mutism but also by long tract signs and neurobehavioral abnormalities whose
cognitive and affective outcome is still a matter of study.”
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Siffert, Poiissaint, Goumnerova, Scott, LaValley, Tarbell, and Pomeroy(2000)
also conducted a study to deteiTnine the features of cerebellar mutism. They observed
a decrease in not only speech output, but also speech comprehension. They also
observed, following treatment, apathy in speech, inattention, eye closure, swallowing
difficulties, hemiparesis, and bowel and bladder malfunction, confirming mutism as
only one of the possible outcomes following posterior fossa tumor treatment. The
more global neurological dysfunctions, including cerebellar dysfunction, expressive
and receptive language difficulties, inattention, apathy, hypokinesis, irritability,
hemiparesis, oromotor apraxia, eye opening difficulty, and bladder control are the
principal reasons for intensive rehabilitation needs. Although symptoms varied in the
children studied, with children demonstrating a decrease in speech output post
surgery, verbal comprehension was most likely to be the initial factor that improved.
The literature cited in this chapter shows that post-treatment communication
and swallowing disorders are common in children with brain tumors, specifically
brain stem gliomas and medulloblastomas. However, the literature does not
sufficiently address the etiology of these communication and swallowing disorders or
the course of clinical treatment and/or treatment setting options needed for these
children, which supports the need for this current research. As the survival rates rise
for these children because of advances in technology and treatments, the importance
of understanding the post-treatment disorders increases. What we know is that
historically brain stem glioma tumors and medulloblastoma tumors are two of the
most prevalent types of brain tumors in children. We also know that treatment for
these tumors often results in speech, language, and/or swallowing disorders, but the
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exact etiology still remains unclear and additional information is needed as to the
nature of these post-treatment disorders and how they are currently managed.
Researchers are still exploring the adverse effects of chemotherapy, radiation, and
surgery for children with brain tumors. This research was directed to study the
prevalence of diagnosed disorders of speech, language, or swallowing in children
with a confirmed brain stem glioma or medulloblastoma tumor, and to provide
additional information on type of disorders noted and the nature of their management.
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CHAPTER THREE
METHODOLOGY
This study was designed to determine if speech-language pathologists (SLPs)
who evaluate children following treatment for brain stem glioma tumors or
medulloblastoma tumors confirm the presence of speech, language, and/or
swallowing disorders. The study also was designed to determine, in the SLP’s
professional opinion, if motor speech was more affected than swallowing in this
clinical population. Specifically the research hypotheses were:
1. There were no diagnosed disorders of speech, language, and/or swallowing
in a child with a brain stem glioma tumor.
2. There were no diagnosed disorders of speech, language, and/or swallowing
in a child with a medulloblastoma tumor.
3. Swallowing disorders were the primary communication disorder identified
and treated by the SLP in children with brain stem glioma tumors.
4. Swallowing disorders were the primary communication disorder identified
and treated by the SLP in children with medulloblastoma tumors.
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Subjects
The subjects for this research project were SLPs who work in pediatric
hospitals where children diagnosed with brain tumors are treated. A minimum of two
pediatric hospitals from each state in the United States was selected, but the number
of surveys sent per state varied. This number varied due to the number of hospitals
found per state that had a pediatric wing or floor and had speech-language pathology
services. The list of hospitals can be found in Appendix C. There was no
discrimination based on gender, race, or age of the subjects in this study.
Procedure
A list of pediatric hospitals in the United States of America, including at least
two pediatric hospitals from each of the 50 states plus one hospital in the District of
Columbia was compiled. A survey containing specific questions about speech,
language, hearing, and swallowing complications in children post medical treatment
for brain stem glioma tumors and/or medulloblastoma tumors was mailed to the
attention of the SLPs at the pediatric hospitals (see Appendix D for a copy of the
survey). A cover letter was included explaining in detail the research project, goals,
and purposes, as well as instructions for completing and returning the questionnaire.
The cover letter can be found in Appendix A and the IRB approval can be found in
Appendix B. To maintain confidentiality during this research project the surveys
were to be anonymously returned (no names or identifying information was to be
included on the surveys). The SLPs were also asked not to include personal
information about themselves or specific children in their answers. Envelopes were
coded to keep track of the hospitals from which the SLPs returned the surveys.
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Follow up letters containing a second copy of the survey were sent if a response was
not received by the requested deadline.
Once the surveys were returned, the data was analyzed. Following
completion of data analysis, surveys were placed in a locked file cabinet in the
Communication Sciences and Disorders Department to assure that no one would have
access to them without permission.
Data
The data were also analyzed, using descriptive data, to determine the
frequency of speech, language, and swallowing disorders, as well as the following:
●

Length of time the SLPs had practiced in the field of Communication
Sciences and Disorders
Length of time SLPs had worked with the pediatric brain tumor population
Types of pediatric brain tumors SLPs evaluated and treated
Types of medical treatment the children with brain tumors had received
Types of communication and swallowing disorders that occurred in
children with brain tumors
Percentage of the SLPs’ patients referred for post medical treatment
evaluation who exhibited speech, language, and/or swallowing disorders
Length of time the speech, language, and/or swallowing problems
persisted post medical treatment
Frequency of SLP treatment with children with brain tumors
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●

Types of follow-up services provided by SLPs for children with
communication and/or swallowing problems associated with medical
treatment for brain stem glioma tumors and/or medulloblastoma tumors

●

“Red flags*’ for SLPs to be aware of when working with children with
brain tumors

29

CHAPTER FOUR
RESULTS

30

CHAPTER FOUR
RESULTS
This study was designed to determine if speech-language pathologists (SLPs),
who work in pediatric hospitals, identified speech, language, and/or swallowing
disorders in children with brain stem glioma tumors or medulloblastoma tumors. A
second purpose in the design was to determine if motor speech or swallowing

was

more affected in a child with a brain stem glioma tumor and in a child with a
medulloblastoma tumor. The third question in this study was to determine the
incidence and treatment of speech, language, and/or swallowing disorders. As stated
in the methodology, the research hypotheses were:
1. There were no diagnosed disorders of speech, language, and/or swallowing
in a child with a brain stem glioma tumor.
2. There were no diagnosed disorders of speech, language, and/or swallowing
in a child with a medulloblastoma tumor.
3. Swallowing disorders were the primary communication disorder identified
and treated by the SLP in children with brain stem glioma tumors.
4. Swallowing disorders were the primary communication disorder identified
and treated by the SLP in children with medulloblastoma tumors.
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A survey of questions for SLPs, who work at pediatric hospitals, was
compiled and sent to the selected SLPs. The questions were designed to survey the
SLPs about speech, language, and swallowing disorders in children with brain stem
gliomas and medulloblastomas following medical treatment. Surveys were mailed to
the SLPs at the chosen hospitals (pediatric hospitals or hospitals with a pediatric
floor). Surveys were initially sent to 72 pediatric hospitals or hospitals with a
pediatric floor covering all 50 states in the United States. Sixteen surveys were
returned initially. Follow-up letters were then sent to the remaining 56 identified
sites. From these 56 hospitals, 29 surveys were returned. A second complete packet
(letters and surveys) was then sent to 48 more hospitals and 12 surveys were returned.
The third complete packet was sent to 25 hospitals and 8 were returned. At the end of
the process, the author had sent 145 suiweys and had a returned total of 65 surveys.
Results of the vai’ious survey questions are displayed in the following figures.
Figures 1, 2, 3 and 7 show both absolute number of returns falling into each category
and the percentage of survey returns that this number represents. Percentages were
not included in Figures 5 and 8 because the SLPs had the opportunity to give multiple
answers to the question.
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15+ yrs,
(15/257c)
0-5yrs,(17/287c)

1 1-15 yrs,
(10/167c)

6-10 yrs,
(19/317c)
Figure I. SLPs' Length of Time in Profession (n=60)

Figure 1 shows the length of time that responding SLPs have practiced in the
field of communication sciences and disorders. Approximately 28%, 31%, 167c, and
257o of SLPs responding have practiced speech-language pathology for 0-5 years, 610 years, 1 1-15 years, and more than 15 years respectively. The majority of SLPs
responding to the survey have practiced six to ten years. The percentage difference
between SLPs who had practiced 0-5 years and 6-10 years (3%), 11-15 years (127c),
and 15+ years (37c) was fairly equally distributed.
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15+ yrs,(7/12%)
1 1-15 yrs,(1/2%)

6-10 yrs,
(\l/297c)

0-5 yrs,(33/57%)

Figure 2. SLPs' Length of Time in Profession Working With Pediatric Brain
Tumors (n=58)

Figure 2 depicts the length of time responding SLPs have worked with the
pediatric brain tumor population. A majority of the SLPs responding have worked
with children with brain tumors for 0-5 years (57%). The next highest was 6-10 years
(29%) This was followed by a significant drop, down to 2% for the 11-15 years
category, and up to 12% for the 15+ years category. These data could be a reflection
of the increase in awareness and diagnosis of pediatric brain tumors during the past
10 years. As identification rates have increased, it can be expected that an awareness
of the effects of the tumors and tumor treatment on communication and swallowing
has also increased, resulting in the need for more SLPs to provide evaluation and
treatment services.
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Figure J. Number of SLPs Sur\ eyed Who Worked With Communieation Disorders
in Children with Brain Stem Gliomas and Medulloblastomas (n=58)

According to Figure 3, of the 58 SLPs, who answered this survey question, 33
(56.9%) had treated communication disorders in children with brain stem glioma
tumors and children with medulloblastoma tumors, while 16 (27.59%) had not
treated children with either type tumor. Five (8.62%) had only treated
medulloblastoma tumors and 4 (6.9%) of the 58 SLPs responding had treated only
brain stem glioma tumors.
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Figure 4. Number of Surveyed SLPs Seeing Children Receiving Various Medical
Treatments for Tumors(n=51)

Figure 4 shows the distribution of various medical treatments which had been
provided to the children with brain stem gliomas and medulloblastomas treated by the
responding SLPs. Thirty-six (70.59%) of the SLPs responding had evaluated and
treated communication disorders in children who had received some form of
chemotherapy, radiation, and/or surgery. This percentage was high compared to the
number of surveyed SLPs who had evaluated and treated children for communication
disorders following only chemotherapy (1.96%), radiation (0%), surgery (5.88%), and
combinations of chemotherapy and radiation (0%), combinations of radiation and
surgery (3.92%), or combinations of chemotherapy and surgery (9.8%). Four
(7.84%) of the SLPs responding had never treated children receiving chemotherapy,
radiation, or surgery, but these four SLPs had also not treated any children with brain
stem gliomas or medulloblastomas, even though they were employed in pediatric
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None

hospitals or hospitals with pediatric floors or wings. These results show the variety of
medical treatments children with these tumors may receive and suggests that
combination medical treatments are more common than single modality treatment.
This data might also suggest that the risk of post-treatment communication disorders
may be higher in children who receive multi-modality medical treatment for brain
tumors. Physicians identified surgery as the primary medical treatment protocol for
children with brain tumors (Black, 2006); however, surveyed SLPs working with this
population stated that most of the children they treated had a combination of medical
treatment as opposed to one type. The reason this is important in the field of
communication sciences and disorders is because of the amount and type of
communication and swallowing disorders SLPs may need to treat as a result of
combination treatments.
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The data in Figure 5 show different types of communication disorders that
SLPs identified in children with brain tumors. Forty-seven (47) SLPs who responded
observed motor speech deficits and 43 observed swallowing disorders. Additional
diagnoses reported include cognition deficits (observed by 41 SLPs), language
processing problems (observed by 38 SLPs), and mutism (observed by 25 SLPs).
The hypothesis, identified in the research questions, was that swallowing would be
the primary communication disorder observed in children with either brain stem
glioma tumors or medulloblastoma tumors, yet this research showed motor speech
deficits to be slightly more prevalent, based on the responses of the SLPs surveyed.
Some other communication disorders observed included word finding difficulties.
memory deficits, pragmatic disorders, feeding complications, and executive
functioning disorders.

<1 wk,(2/4%)
1 wk-lmth,
(6/1 1%)

>6 mths,
(27/48%)

1-3 mths,
(12/21%)

3-6 mths,
(9/16%)
Figure 6. Length of Time Speech, Language, Hearing or Swallowing
Disorders Persisted After Medical Management(n=56)

38

The next survey question (Figure 6)asked the SLPs how long the
communication disorders, swallowing, and/or hearing disorders persisted after
medical treatment (e. g. chemotherapy, radiation, and/or surgery). Twenty-seven
(48%)of the SLPs responded that the children on their caseload exhibited
communication, swallowing, or hearing disorders for more than 6 months following
medical treatment. Twenty-one percent(21%)of SLPs reported these disorders
persisting for 1 to 3 months after medical treatment, sixteen percent(16%)reported
problems persisting for 3 to 6 months and eleven percent(11%)reported problems
persisting for 7 days to 30 days. The question regarding length of time residual
communication and swallowing disorders persisted was included in order to improve
understanding of the role of speech-language pathology in the therapy regimen for
children with these two types of brain tumors. It seems reasonable to assume that the
longer the communication and swallowing disorders persist, the greater the impact on
the child’s life. Persistent communication problems might also have an impact on the
child’s educational progress. Additional allied health services could include physical
therapy, occupational therapy, behavioral therapy or case management and social
work intervention. When this occurs, the economic impact on families, school
systems, and other social systems must be considered (B. Foley, L. P. Barakat, A.
Herman-Liu, J. Radcliffe & P. Molloy, 2000).
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ni\2%)

4-5 hrs/wk.
(I l/197c)
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(4/77f)
2-3
1 -2 hrs/wk,
(3/5%)

(16/28%)

Figure 7. Frequency of Treatment for Children with Pediatric Brain Tumors
(11=49)

The majority of children received treatment from an SLP less than one hour
per week (29% according to Figure 7). However, a close second was the number of
responding SLPs(28%) who treated the children on their caseload for 1 to 2 hours petweek. Nineteen percent of responding SLPs(19%)treated children 4 to 5 hours petweek, 12% treated children for more than 5 hours per week,7% treated children for 3
to 4 hours per week, and 5% treated children 2 to 3 hours per week. The frequency of
treatment depended on the type of communication disorder and the progress of the
children as communication and swallowing therapy continued. Once again, these
results represent a wide variation in the amount of services required for children with
brain tumors, specifically brain stem gliomas and medulloblastomas.
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Fifiure 8. Types of Follow-up Treatments for Children with Brain Stern
Gliomas and Medulloblastomas (n=50)

Responding SLPs were asked to discuss follow-up service provided for
children with brain tumors after completion of SLP evaluations and treatments
(Figure 8). The options included: a) treating children for as long as communication,
swallowing, or hearing problems persisted, b) referring children to outpatient SLP
services, c) working with the educational (school) team to transition children, d) re¬
evaluating children periodically, and e) other services (listed in the narratives
Appendix E). Forty (40) of the responding SLPs referred the children to outpatient
SLP services. The next most frequent form of follow-up service was working with an
educational team to transition the children back into their school program (28 SLPs).
Twenty two (22) SLPs responding stated they also treat the children as long as
problems persist and 21 of the SLPs responding stated they re-evaluated the children
periodically to check for changes in the communication, swallowing, or hearing
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disorders. Some of the other follow-up services mentioned in the narrative portion of
the SLPs’ answers included modified barium swallowing studies, cognitive
evaluations, inpatient rehabilitation, transferring children to inpatient rehabilitation
hospitals, feeding treatments, and transitioning between inpatient SLP services,
outpatient SLP services, and/or other rehabilitative services (e.g. occupational therapy
and physical therapy).
The surveys also inquired about what percentage of the SLPs’ caseloads
exhibited speech and/or swallowing problems following medical treatment for
pediatric brain tumors (question #6 from survey. Appendix D). The percentages
ranged from 25% of the children to 100% of the children. Three SLPs stated that
25% of their children exhibited speech and/or swallowing issues, one estimated 30%,
six estimated 50%, three estimated 70%, six estimated 75%, three estimated 80%,two
estimated 85%,two estimated 90%, one estimated 95%, and nine estimated 100%.
This showed the variation in the amount of children exhibiting speech and/or
swallowing disorders post-medical treatment, according to the responding SLPs.
Three SLPs also answered that the number of children they have treated in their
experience depended on the location of the tumor, the treatment course selected, and
whether or not children received speech-language pathology services before being
refened to this specific SLP. Also one of the SLPs stated that they treated only
children with cognitive or swallowing deficits, so all referrals to them would have one
or both of these disorders.
In conclusion, the findings of this study indicate the following:
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1.

SLPs may have job opportunities in hospitals or units where children with
tumors receive medical treatment and then need the clinical treatment of an
SLP for the communication and/or swallowing complications that occur as a
result of the tumors or the resection of the tumors. SLPs may have very little
experience in the field of communication sciences and disorders, much less
with the pediatric tumor population when they take these jobs. The lack of
experience may be exacerbated by the lack of peer mentoring available to
them, leaving them to “learn on the job” with this population. The study also
shows that SLPs do remain or take these jobs later in their career, also,
although prior experience to the pediatric hospitals and units is unclear at this
time based on this study. This would be a question for the next step of the
study.

2. The majority of responding SLPs(72.42%) had experience working with
children recovering from brain stem gliomas and/or medulloblastomas. As
the author previously stated, these two tumors are two of the most frequently
identified tumors in the pediatric population. Thus this author is comfortable
in stating that SLPs working in pediatric tumor centers will likely be called
upon to treat children recovering from these type tumors. SLPs need to
appreciate the differences and similarities among the various tumors
commonly found in the pediatric population, as well as the resultant
communication and swallowing problems associated with medical treatment
of these tumors.

43

3. This study also confirms, albeit with a small sample size, that many children
diagnosed with tumors will receive a combination of three medical
interventions (chemotherapy, radiation, and surgery), rather than a single
intervention or two interventions. Secondary clinical complications such as
motor speech, language, and swallowing problems appear to occur more
frequently when multi-modality medical interventions are required. .
4. The SLPs surveyed identified the five most common types of communication
and swallowing disorders that occur in children who have either of these
tumors. These include motor speech disorders, mutism, cognitive disorders.
language processing disorders, and swallowing disorders.
5. The SLPs surveyed also confirmed that these communication and/or
swallowing disorders persist for longer than six months, thus creating
additional challenges in the areas of education, independent living, and
community based activities. This fact also bears the question of whether the
field has SLPs qualified in the outpatient and home health arenas to continue
the treatment regime started in the pediatric hospitals and units for children
with brain tumors.
6. The study confirms that the greatest number of these children is referred to
outpatient facilities or into the local educational system for continued services
following hospital discharge. This raises questions regarding the availability
of local resources, adequately trained teacher and community services needed
to provide the quality care required for these children to make maximum re¬
integration into society.
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This study suggests that additional research is needed in this area in order to
improve the general knowledge base of SLPs regarding brain tumors in the pediatric
population, as well as to provide a second tier of specific training and mentoring for
SLPs who work in these facilities. This is discussed further in Chapter Five.
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CHAPTER FIVE
DISCUSSION
Summary
Brain tumors are one of the two most common sites of childhood cancer. In
2007-2008 between 3,500 and 3,750 children were expected to be diagnosed with
brain tumors amuially (Central Brain Tumor Registry of the United States, 20072008). Pediatric brain tumors are classified according to location, size, and cell
origin. These factors determine the course of medical treatment for the child.
Medical treatment can include surgery, radiation, and/or chemotherapy and often
results in post-treatment problems in the areas of motor speech, language, and/or
swallowing.
This study was designed to determine if speech-language pathologists (SLPs),
who work in pediatric hospitals, frequently identify and treat speech, language, and/or
swallowing disorders in children following medical treatment for brain stem glioma
tumors or medulloblastoma tumors. A second puipose in the design was to determine
it motor speech or swallowing was more frequently affected. Specifically the
research hypotheses were:
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1. There were no diagnosed disorders of speech, language, and/or swallowing
in a child with a brain stem glioma tumor.
2. There were no diagnosed disorders of speech, language, and/or swallowing
in a child with a medulloblastoma tumor.
3. Swallowing disorders were the primary communication disorders identified
and treated by the SLP in children with brain stem glioma tumors.
4. Swallowing disorders were the primary communication disorders identified
and treated by the SLP in children with medulloblastoma tumors.
The subjects for this study were SLPs at pediatric hospitals across the United
States of America. At least two hospitals in each of the 50 United States and one
hospital in the District of Columbia were chosen from the American Hospital
Directory website (http://www.ahd.com) and the U.S. News and World Report
website (http://health.usnews.com/sections/health/best-childrenshospitals/index.html). These hospitals either had a pediatric wing, where children
were treated, or were pediatric hospitals, defined by the fact that they treated only
children. A questionnaire survey was sent to the SLPs asking them to report, from
their experience, the prevalence of speech, language, and swallowing disorders in
children with brain stem glioma tumors or medulloblastoma tumors. One hundred
forty-five (145)surveys were sent with 65 final responses received. From the western
United States 11 surveys were returned, 26 from the Midwest, 19 from the South, and
8 from the Northeast(Appendix F).
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General Discussion
After compiling the survey results, it was found that SLPs observed 11
different communication disorders, contrary to the first and second original
hypotheses that no diagnosed disorders of speech, language, and/or swallowing were
present in the children evaluated in their facilities who had the medical diagnosis of
brain stem glioma or medulloblastoma. Surveys returned from 47 SLPs stated they
observed motor speech disorders following medical treatment(chemotherapy,
radiation, and/or surgery) while surveys returned from 43 SLPs confirmed they
observed swallowing disorders. This difference may be an indicator of an increase in
either the number of swallowing disorders related to these two types of tumors or an
increase in the ability to identify swallowing disorders following medical
intervention. The difference could also be an indicator of a decrease in identified
motor speech disorders. If additional SLPs or SLPs in different types of facilities
were questioned, it is possible the difference between these two disorders would be
weighted in favor of motor speech disorders. In addition, other communication
disorders were observed by the SLPs including mutism, cognition deficits, language
processing problems, word finding difficulties, pragmatic issues, memory disorders,
feeding aversions, hardening of the tympanic membrane, and executive function
issues. The incidence of additional communication disorders beyond the most
obvious motor speech and swallowing disorders suggests that SLPs need to evaluate
all children treated for brain tumors
The literature also cites the presence of cognitive and psychological disorders
including depression, withdrawal, and anxiety (Poggi, et. al., 2004). as well as motor

49

speech, language, and swallowing issues (Goncalves, et. al„ 2006). In the literature
cognitive disorders correlate with learning difficulties, indicated by lowered scores in
the areas of reading, spelling, and mathematics (Poggi, et. al., 2004). The results of
the current study confirm, according to the SLPs who responded, that cognitive and
psychological disorders were observed in the pediatric brain tumor population. In
future research more detailed information regarding these identified disorders should
be obtained. In addition to the presence of cognitive and psychological disorders, an
article by Levisohn, et. al., in 2000 cites the presence of executive fimctioning
impairments in children with these particular brain tumors. One of the SLPs
responding to the survey listed executive functioning impairments as a disorder found
in children with brain tumors. The Levisohn article (2000) discussed memory deficits
(a type of executive functioning impairment), which were also listed by one of the
responding SLPs.
Mutism in children with brain tumors was reported by 25 of the 65 responding
SLPs. Postoperative mutism is mentioned in the literature, specifically posterior
fossa syndrome, as occurring in tumors in the brain stem and the cerebellum (Hudgins
& Edwards, 1987). According to an article by Stargatt et al (2007), because posterior
fossa tumors arise from the cerebellum and adjacent structures, the tumors and their
subsequent surgical resection can damage the cerebellum and/or adjacent structures.
The cerebellum controls motor function and cognitive function so the damage may
affect these functions and lead to the development of posterior fossa syndrome. Both
brain stem gliomas and medulloblastomas are posterior fossa tumors, therefore the
correlation with mutism.
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Overall, the results of this pilot study led to tlie rejection of the researcher's
first and second hypotheses since communication and/or swallowing disorders were
identified by SLPs, while the results failed to lead to the rejection of the third and
fourth hypotheses since there was not enough of a difference in the number of
identified motor speech disorders and swallowing disorders to be measured as
significant. SLPs observed speech, language, and/or swallowing disorders in children
diagnosed with brain tumors. A higher incidence of communication disorders
identified in children with brain tumors in this study were motor speech disorders,
although a variety of other communication disorders were identified by the SLPs as
well.
Strengths and Limitations of Current Research
This current study was approached as a pilot study, but does, in the author s
opinion, have several strong points. Information on the prevalence of communication
disorders was collected from SLPs who evaluate and treat children diagnosed with
brain tumors, specifically medulloblastoma tumors and brain stem glioma tumors.
This improves our understanding of the role of speech-language pathology with this
population. SLPs in a variety of geographic locations were surveyed in an attempt to
eliminate geographic bias. This allowed for a broader range of SLP exposure and
experiences. The SLPs who worked in hospitals in cities or states with larger
populations would have more exposure due to the large population. SLPs in smaller
hospitals or cities or states with smaller populations would have less exposure based
on the population. Also, in smaller states children with brain tumors could be sent to
hospitals in bigger states or to the nearest city in a different state (especially in the
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Northeast United States) which would affect the caseloads of the SLPs. By focusing
on two types of tumors, the response possibilities were narrowed, allowing a clearer
understanding of the results. However, the information obtained was restricted to
only two specific tumors. The two types of tumors chosen both originate in the
posterior fossa region of the brain. This lends consistency to attempts to relate site of
tumor origin and secondary damage/complications.
The study was limited in the following ways: a) the varying number of
facilities identified as providing SLP services for children with brain tumors per state,
b) the types of residual communication disorders observed by SLPs was not
con'elated with a specific type of tumor and c) information gathered about type of
communication disorders was not tumor specific.
The number of surveys sent to each state could have been the same in order to
improve the consistency of the study. The fact that a different number of surveys was
sent to different geographic regions accounts for the higher number of returns in one
geographic area over another.
To gain a better understanding of each tumor, it would have been helpful to
ask about the communication problems associated with each tumor individually.
Another limitation was the difficulty associated with analyzing the narrative
responses of the SLPs. Two of the questions on the survey allowed a narrative
answer, but the answers provided were so general that accurately interpreting the
responses was difficult. Since there is no generally agreed upon standard of care for
children with different types of tumors, evaluation and treatment protocols vary
greatly, and therefore SLPs’ responses to the questions vai'ied greatly.
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Although this study could have been more specific in some areas, it did
answer the original research questions posed and provided information which should
be useful in planning for additional research on the treatment of communication and
swallowing disorders in children with brain tumors. The author is in the process of
preparing the infomiation for publication.
Sui^f^estionsfor Future Research
The study should be expanded to include additional types of brain tumors and
to investigate in more detail the etiology and treatment of communication deficits
occuiTing post medical treatment.
In order to expand this study, tumors that originate in other portions of the
brain besides the posterior fossa should be included. The differences between
residual communication deficits appearing in posterior fossa tumors and in other
tumors could then be further explored.
Another way to extend the study would be to ask more specific questions
about the types of treatments SLPs perform. The correlation between the type of
clinical and medical treatment performed and the type of tumor could be investigated.
Also, the rationale underlying the SLP’s treatment plan could be explored. A
comprehensive understanding of the treatment plan could assist individuals planning
to practice in the field.
Finally, the etiology of the communication and swallowing disorders could
continue to be researched. If the etiology can be found, then there may be a way to
prevent the communication and swallowing disorders from occurring. The SLP could
then work with the oncology team to form a treatment plan that would hopefully
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prevent any disorders after clinical and medical treatment. Ideally, this would reduce
the residual communication and swallowing disorders from chemotherapy, radiation,
surgery, and/or the brain tumor itself. The field of communication sciences and
disorders is constantly changing, as is research about pediatric brain tumors. The
combinations of medical research and clinical research on communication and
swallowing disorders may eventually lead to a standard protocol or best practice for
treatment of children with brain tumors which would apply across various practice
settings.
Summary
This student research project set out to investigate the role of speech-language
pathology in the management of children with brain tumors. More specifically, the
research questions addressed whether or not speech, language, and/or swallowing
disorders were present in children with brain stem glioma tumors and/or
medulloblastoma tumors. The research questions also examined whether motor
speech or swallowing disorders were the most prevalent in children with brain stem
gliomas and/or medulloblastomas. SLPs in pediatric hospitals or hospitals with
pediatric wings answered surveys containing questions about issues such as the length
of time the SLPs had worked in the field, the length of time the SLPs had worked
with children diagnosed with brain tumors, the types of tumors the SLPs had
evaluated and treated, how often clinical treatment was provided, which types of
communication deficits, if any, the SLPs saw, and what types of treatment the SLPs
provided.
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The results of this experiment confirmed that speech, language, and/or
swallowing problems were present in 100% of the children seen by the responding
SLPs after medical treatment for a pediatric brain tumor. The results also showed
that the SLPs surveyed observed motor speech deficits more often than swallowing
problems. Additional problems that SLPs observed frequently included mutism,
cognitive deficits, and language processing problems. This survey shows that the
prevalence of residual communication disorders will depend on the location, size, and
cell origin of the tumor, but can also be related to the type of medical treatment
prescribed. The fact that 72.42% of respondents had experience working with
children diagnosed with brain stem glioma tumors and/or medulloblastoma tumors
supports the need for SLP services in this population of children.
The strengths of this research project included the wide range of geographic
locations sampled, the homogenous nature of the sites (all were pediatric hospitals
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hospitals with a pediatric floor), the limited range of tumors t)q)es researched, and the
fact that both of the tumors chosen originated from the posterior fossa region of the
brain. The limitations of this research project were the variations in the number of
surveys sent to each state, the lack of specificity in some of the survey questions, and
the difficulty in analyzing the narrative answers due to the wide variety of answers
received.
Future research should address these limitations and address the etiology of
the residual communication disorders. Once the etiology of the brain tumors is better
understood, then a better clinical and medical treatment regimen for the child can be
implemented. Future research will help SLPs better understand the etiology of the
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communication deficits that result because of the type of tumor, and medical
treatment received by the child. This will allow the SLPs to develop a clinical
treatment plan earlier and one that will better serve the needs of the individual child.
Every child is such a valuable human being and children with brain tumors deserve
every scientific advancement possible on their behalf.

56

LIST OF REFERENCES

57

LIST OF REFERENCES
(2005). Steelman's Medical Dictionary. Baltimore: Lippincott Williams & Wilkins.
(2008, August 6). American Hospital Directory. Retrieved March 2, 2008, Web site:
http://www.ahd.com/
Aarsen, F. K., Van Dongen, H. R., Paquier, P. F., Van Mourik, M.,& CatsmanBerrevoets, C. E.(2004). Long-term sequelae in children after cerebellar
astrocytoma surgery. Neurology, 62, 1311-1316.
Achenbach, T. M., Edelbrock, C.(1983). Manualfor the Child Behavior Checklist
and Revised Child Behavior Profde. Vermont: Burlington.
Al-Shatoury, H. A. H., Galhom, A. A., Engelhard III, H. H.(updated 2008) Posterior
Fossa Tumors, emedicine. Retrieved February 25, 2008,from
http://emedicine.medscape.com/article/249495-overview.
Anderson, V., & Taylor, G.(1999). Meningitis. In K. Yeates, M. D. Ris, & H.G.
Taylor (eds.). Pediatric neuropsychology: Research, theory, and practice,
117-148. New York: Guildford Press.
Anderson, V., Northam, E., Hendy, J., & Wrennal, J.,(eds.)(2001). Developmental
Neuropsychology: A Clinical Approach, Hove, East Sussex, U.K.:
Psychology Press, Taylor & Francis Group.
Anderson, V., Smibert, E., Ekert, H., & Godber, T.(1994). Intellectual, Educational,
and Behavioral Sequelae after Cranial Irradiation and Chemotherapy.
Archives ofDiseases in Childhood, 70. 476-483.
Bailey P., Cushing H.(1925). A common type of midcerebellar glioma of
childhood. Archives of Neurology. 14, 192-224
Beebe, D.W. Ris, M. D., & Holmes, E.(2001) Location may not affect IQ and
adaptive outcomes in pediatric cerebellar tumors. Presented at International
Neuropsychology Society Conference, Toronto.
Beery, K. E., Buktenica, & Beery, N. A.(2006). Beerv Visual Motor Integration
(VMI)
Benesch, M., Lackner, H., Moser, A., Kerbl, R., Schwinger, W., Oberbauer, R., Eder,
H., Mayer, R., Wiegele, K., & Urban, C.(2001). Outcome and Long-Term
Side Effects after Synchronous Radiochemotherapy for Childhood Brain
Stem Gliomas. Pediatric Neurosurgery. 35, 173-180.

58

Black, P.(2006). Living with a Brain Tumor: Dr. Peter Black's Guide to Taking
Control of Your Treatment. Macmillan.
Blair, J. C., Peterson, M. E., Viehweg, S. H.(1985). The effects of mild sensorineural
hearing loss on academic performance of young school age children. The
Volta Review. 87. 87-93.
Blakely, B. W., Myers, S. F.(1993). Patterns of Hearing Loss Resulting from
Cisplatinum Therapy. Otolaryngology Head Neck Surgery, 109. 385-391.
Boghen D, Aoichane M (1991). Pupillary area activity in hydrocephalus of recent
onset. Canadian Journal of Neurological Sciences. 18, 510-511.
Brock. P. R., Bellman, S. C., Yeomans, E. C. et al. (1991). Cisplatin ototoxicity in
children: A practical grading system. Medical and Pediatric Oncology, 19.
295-300.
Capodano A. M . Nervous system: Ependymomas. Atlas Genet Cytogenetics
Oncology Hematology. April 2001 . URL :
http://AtlasGeneticsOncology.org/Tumors/EpendymomID5016.html
Caipentieri, S.C., Waber, D.P., Pomeroy, S.L., Scott, R.M., Goumnerova, L.C.,
Kieran, M.W., Billett, A.L., Tarbell, N.J.(2003).Neuropsychological
Functioning After Surgery in Children Treated for Brain Tumor.
Neurosurgery. 52, 1348-1357.
Central Brain Tumor Registry of the United States.(2007-2008). Primary Brain
Tumors in the United States Statistical Report. Retrieved February 4, 2008,
from Central Brain Tumor Registry of the United States v^ebsite:
http://www.cbtrus.Org/reports//2007-2008/2007report.pdf
Clerico, A., Sordi, A., Ragni, G., Festa, A., Cappelli, C., Maini, C.L.(2002).Transient
Mutism Following Posterior Fossa Surgery Studied by Single Photon
Emission Computed Tomography(SPECT). Medical and Pediatric Oncology.
38,445-448.
Copeland, D., De Moor, C., Moore, B., & Ater, J.(1999) Neurocognitive
Development of Children after a Cerebellar Tumor in Infancy: A
Longitudinal Study. Journal of Clinical Oncology, 17, 3476-3486.
Cousens, P., Waters, B., Said, J., & Stevens, M.(1988). Cognitive Effects of Cranial
Irradiation in Leukemia: A Survey and Meta-analysis. Journal of Child
Psychology and Psychiatry, 29. 839-852.
Disease Information. Astrocytoma/Glioma,(n. d.) Retrieved February 4, 2008, from
St. Jude Children’s Research Hospital web site:
http.7/www.stjude.org/stjude/v/index.jsp?vgnextoid=6f2b061585f701 lOVgn
59

VCM1000001e0215acRCRD&vgnextchannel=b4dcbfe82e1180lOVgnVC
M1000000e2015acRCRD
Disease Information. Brain Tumor: Brain Stem Gliomas,(n. d.) Retrieved February 4,
2008, from St. Jude Children’s Research Hospital web site:
http://www.stjude.org/stjude/v/index.jsp?vgnextoid=b86c061585f701 lOVgn
VC M1000001e0215acRCRD&vgnextchannel=b4dcbfe82e11801OVgnVC
M1000000e2015acRCRD
Disease Information. Mednllohlastoma/PNET.(n. d.) Retrieved February 4, 2008,
from St. Jude Children Web site:
http://www.stjude.org/stjude/v/index.jsp?vgnextoid=070b061585f701 lOVg
nVCM1000001e0215acRCRD&vgnextchannel=b4dcbfe82ell8010VgnVC
M1000000e2015acRCRD
Docking, K. M., Ward, E. C., & Murdoch, B. E,(2005). Language Outcomes
Subsequent to Treatment of Brainstem Tumour in Childhood.
NeiiroRehahilitation. 20, 107-124.
Dodd, B., Holm, A., Oerlemans, M.,& McCormick, M.(1996). Queensland
University Inventory^ ofLiteracy, Department of Speech Pathology &
Audiology, The University of Queensland, St. Lucia.
Doxey, D, Bruce, D, Sklar, F, Swift, D,& Shapiro, K (1999). Posterior Fossa
Syndrome: Identifiable Risk Factors and Irreversible Complications.
Pediatric Neurosurgery. 31, 131-136.
Dunn, L. M.,& Dunn, L. M.(1997). Peabody Picture Vocabulary Test,(Third ed.),
American Guidance Service, Circle Pines.
Ehrenhaus, M. P., & Hajee, M. E.(2006). Abducens Nerve Palsy, emedicine.
Retrieved January 26, 2009, from
http://emedicine.medscape.eom/article/l 198383-overview.
Elliott, C. D.(1990). The Differential Abilities Scale. The Psychological Coiporation.
Fisher, J. P., & Glenister, J. M.(1992). The Hundred Pictures Naming Test, The
Australian Council for Educational Research Ltd., Melbourne.
Foley, B., Barakat, L. P., Herman-Liu, A., Radcliffe, J., & Molloy, P.(2000). The
Impact of Childhood Hypothalamic/Chiasmatic Brain Tumors on Child
Adjustment and Family Functioning. Childrens Heath Care. 29, 209-223.
Gajjar, A & Doyle, T.(n. d.). Treatment of Patients with Newly Diagnosed
Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor
(PNET), or Atypical Teratoid Rhabdoid Tumor(ATRT). Retrieved
60

Febmary 4, 2008, from St. Jude Children's Research Hospital Web site:
http://www.stjude.org/stjude/v/index.jsp?vgnextoid=034e722d99f70110Vgn
VC M1000001e0215acRCRD&vgnextchannel=4931 bfe82e118010VgnVC
M1000000e2015acRCRD&SearchUrl=search_results.jsp&QueryText=treat
ment%20of%20patients%20with%20%20newly%20diagnosed%20medullo
blastoma
Gardner, M. F.(1990). Gardner Expressive One-Word Picture Vocabulary TestRevised. Psychological and Educational Publications, Inc.
Gilmer Knight, K. R., Kraemer, D. F., Neuwelt, E. A.(2005).0totoxicity in Children
Receiving Platinum Chemotherapy: Underestimating a Commonly
Occurring Toxicity That May Influence Academic and Social Development.
Journal of Clinical Oncology. 23, 8588-8596.
Goncalves, M. I., Radzinsky, T. C., Saba da Silva, N, Chiari, B. M.,& Consonni, D
(2006). Speech-Language and Hearing Complaints of Children and
Adolescents with Brain Tumors. Pediatric Blood Cancer.
Greenberg M. S.(1997). Astrocytoma. In: Handbook of Neurosurgery (pp. 244256). Vol 1. 4^*^ ed. Lakeland, Fla: Greenberg Graphics Inc.
Heideman, R., Packer, R., Albright, A. L., Freeman, C. R., and Rorke, L. B.(1997).
Tumors of the Central Nervous System. In P. A. Pazzo & P. D. Poplack
(ed.). Principles and Practice ofPediatric Oncology (3*^^ ed., pp. 633-697).
Philadelphia: Lippincott-Raven.
Hoppe-Hirsch, E., Renier, D., Lelliuch-Tubiana, A., Sainte-Rosen, C., Pierre-Kahn,
A. Hirsch, J. F. et al.(1990). Medulloblastoma in Childhood: Progressive
Intellectual Deterioration. Child's Nervous System, 6, 60-65.
How pediatric brain and spinal cord tumors are diagnosed. Retrieved February 4,
2008,from Pediatric Brain Tumor Foundation Web site:
http://www.pbtfus.org/families/parents/diagnosis.html
Hudgins, R.J., Edwards, M.S.B.(1987).Management of infratentorial brain tumors.
Pediatric Neuroscience. 13, 214-222.
Hudson, L.J., Murdoch, B. E.(1992). Chronic language deficits in children treated for
posterior fossa tumour. Aphasiology. 6, 135-150.
Humphreys, R (1989). Mutism after posterior fossa tumor surgery. Con Pediatric
Neurosurgery. 9, 57-64.

61

Ilveskoski, I., Saarinen, U. M., Wiklund, T., et al.(1998). Ototoxicity in children with
malignant brain tumors treated with the “8 in 1” chemotherapy protocol.
Medical and Pediatric Oncology, 17. 26-31.
Jacobs, R., Northam, E., & Anderson, V.(2001)Cognitive Outcome in Children with
Myelomeningocele and Perinatal Hydrocephalus: A Longitudinal
Perspective. Journal ofDevelopmental and Physical Disabilities, 13, 389404.
Karatekin, C. L., Lazareff, J.A., & Asamow, R. F.(2000). Relevance of the
Cerebellar Hemispheres for Executive Functions. Pediatric Neurology, 22,
106-112.
Lalonde, R. & Botez-Marquard, T.(2000). Neuropsychological deficits of patients
with chronic or acute cerebellar lesions. Journal ofNeurolinguistics, 13,
117-128.
Le Barro, A., Zeltzer, P., Zeltzer, L., Scott, S., & Martin, A.(1988). Assessment of
Quality of Survival in Children with Medulloblastoma and Cerebellar
Astrocytoma. Cancer, 62, 1215-1222.
Levisohn, Lisi, Cronin-Golomb, Alice, & Schmahmann, Jeremy D.(2000).
Neuropsychological Consequences of Cerebellar Tumour Resection in
Children. Brain. 123, 1041-1050.
Li, Y., Womer, R. B., Silber, J. H.(2004). Predicting ototoxicity in children:
Influence of age and the cumulative dose. European Journal of Cancer. 40.
2445-2451.
McGrew & Flanagan.(1998). Naming Vocabulary. The Psychological Corporation.
Merchant, T.(2008). 3D Radiation—Preserving Brain Function. Retrieved February
4, 2008, from St. Jude Children's Research Hospital Web site:
http://www.stjude.org/stjude/v/index.jsp?vgnextoid=eff42066d5e701 lOVgn
VCM100000le0215acRCRD&vgnextchannel=f9e6del2071180lOVgnVC
M1000000e2015acRCRD
Micklewright, J., King, T., Morris, M.,& Morris, R.(2007). Attention and memory in
children with brain tumors. Child Neuropsychology, 13, 522-527.
Montaguti, M., Brandolini, C., Ferri, G. G., et al.(2002). Cisplatin and carboplatininduced ototoxicity in children: Clinical aspects and perspectives for
pvQWQwixon. Acta Otohinolaryngology Italia, 22. 14-18.
Packer, R. J.(1999).Brain Tumors in Children. Archives of Neurology. 56, 421-425.

62

Packer, R.J., Sposto, R., Atkins, T.E., et al (1987).Quality of life in children with
primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa.
Pediatric Neuroscience. 13, 169-175.
Packer, R. J., Sutton, L. N., Atkins, T. E., Radcliff J., Bunin, G. R., D’angio G., et al.
(1989). A Prospective Study of Cognitive Function in Children Receiving
Whole-brain Radiotherapy and Chemotherapy: 2 Year Results. Journal of
Neurosurgery, 70, 707-713.

Palmer, S. L., Gajjar, A., Reddick, W. E., Glass, J. O., Kun, L. E., Wu,S., et al.
(2003). Predicting Intellectual Outcome Among Children Treated with 3540 Gy Craniospinal Irradiation for Medulloblastoma. Neuropsychology, 17,
548-555.
Papazoglou, A., King, T. Z., Morris, R. D., Krawiecki, N. S.(2008). Cognitive
Predictors of Adaptive Functioning Vary According to Pediatric Brain
Tumor Location. Developmental Neuropsychology. 33, 505-520.
Pence, K. L., & Justice, L. M.(2008). Language Developmentfrom Theory to
Pracr/c£?.Upper Saddle River, NJ: Pearson Prentice Hall.
Pfefferbaum-Levine, B., Copeland, D., Fletcher, J., Reid, H., Jaffe, N. & McKinnon,
W.(1984). Neuropsychological Assessment of Long-term Survivors of
Childhood Leukemia. American Journal ofPediatric
Hematology/Oncology, 6, 123-128.
Poggi, G, Liscio, M,Galbiati, S, Adduci, A, Massimino, M,Gandola, L, Spreafico, F,
Clerici, Carlo A., Fossati-Bellani, F, Sommovigo, M,and Castelli, E(2004).
Brain Tumors in Children and Adolescents: Cognitive and Psychological
Disorders at Different Ages. Psycho-Oncology. 14, 386-395.
Pollack, I., Polinko, P., Albright, A., Towbin, R., Fitz, C.(1995). Mutism and
pseudobulbar symptoms after resection of posterior fossa tumors in
children: incidence and pathophysiology. Neurosurgery. 37, 885-893.
Rekate, H.L., Grubbe, R.L., Aram, D.M., et al.(1985). Muteness of cerebellar origin.
Archives ofNeurology. 42, 697-698.
Rey, A.(1958). L'examen clinique en psychologie. Paris: Presse Universitaire de
France.
Riva, D., & Giorgi, C.(2000). The Cerebellum Contributes to Higher Functions
During Development. Brain, 123, 1051-1061.

63

Riva, D., Panelaeoni, C., Milani, N.,& Fossati, F.(1989). Impairment of
Neuropsychological Functions in Children with Medulloblastomas and
Astrocytomas in the Posterior Fossa. Child's Nervous System, 5, 107-110.
Robertson, P. L.(1998). Pediatric brain tumors. Primary Care. 25, 323-339.
Rood, B.(n. d.). Infantile brain tumors. The Childhood Brain Tumor Foundation.
Sala, F., Colarusso, E., Mazza, C., Talacchi, A., & Bricolo, A.(1999). Brain Tumors
in Children Under 3 Years of Age. Pediatric Neurosurgery, 31,from
w w w.karger.com/joumals.
Schmahmann, J. D., & Pandya, D. N.(1997). The Cerebellar System. International
Review of Neurobiology, 41, 31-60.
Scott, R., Stoodley, C. J., Anslow, P., Paul, C., Stein, J., Sugden E., et al.(2001).
Lateralized Cognitive Deficits in Children Following Cerebellar Lesions.
Developmental Medicine and Child Neurology, 43, 685-691.
Segal, G., Levin, V. A., Steiger, B., «& Falk, D.(1991). A Primer of Brain Tumors: A
Patient's Reference Manual. 5, Retrieved March 4, 2009,from:
http://neurosurgery.mgh.harvard.edU/abta/primer.htm#Section8.
Semel, E., Wiig, E. H., & Secord, W. A.(1995). Clinical Evaluation ofLanguage
Fundamentals,(Third ed.). The Psychological Corporation, San Antonio.
Siffert, J., Young Poussaint, T., Goumnerova, L.C., Scott, R.M., LaValley, B.,
Tarbell, N.J., Pomeroy, S.L.(2000).Neurological dysfunction associated
with postoperative cerebellar mutism. Journal ofNeuro-Oncology. 48, 7581.
Skarin, A (2001).Diagnosis in Oncology. Journal of Clinical Oncology. 19, 273-278.
Skinner, R., Pearson, A. D., Amineddine, H. A., et al.(1990). Ototoxicity of
cisplatinum in children and adolescents. British Journal of Cancer, 61. 927931.
Sparrow, S. S., Balia, D. A., & Cicchetti, D. V.(1984). Interview edition surveyform
manual: Vineland adaptive behavior scales. Circle Pines, Minnesota:
American Guidance Services.
Spiegler, B. J. , Bouffet, E., Greenberg, M. L., Rutka, J. T., & Mabbott, D. J.(2004).
Change in neurocognitive functioning after treatment with cranial radiation
in childhood. Journal of Clinical Oncology. 22, 706-713.

64

Stargatt, R, Rosenfeld, J.V., Maixner, W,& Ashley, D (2007). Multiple Factors
Contribute to Neuropsychological Outcome in Children With Posterior
Fossa Tumors. Developmental Neuropsychology^ 32, 729-748.
Tomita, T (2000). The Child's Doctor. Retrieved February 25, 2008, from Pediatric
Brain Tumors—Overall Review Child's Doctor Fall 2000 Web site:
http://www.childsdoc.org/fall2000/braintumors.asp
Torgeson, J. K., & Bryant, B. R.(1994). Test ofPhonological Awareness, PRO-ED,
Inc., Austin.
U. S. News and World Report. Retrieved March 2, 2008,from Best Children’s
Hospitals Web site: http://health.usnews.com/sections/health/best-childrenshospitals/index.html
Wechsler (1945). Logical Memory Passagesfor Children.
Wechsler, D.(1989). Manualfor the Wechsler Preschool and Primary Scale of
Intelligence- Revised. San Antonio, TX: the Psychological Corporation
Wiig, E. H. & Secord, W.(1989). Test ofLanguage Competence-Expanded Edition,
The Psychological Corporation, San Antonio.
Wiig, E. H.& Secord, W.(1992). Test of Word Knowledge, The Psychological
Corporation, San Antonio.
Wiig, E. H., Secord, W. A., & Semel, E.,(1992). Clinical Evaluation ofLanguage
Fiindamentals-Preschool. The Psychological Corporation, San Antonio.
Wisoff, J., Epstein, F.(1984). Pseudobulbar Palsy after posterior fossa operation in
children. Neurosurgery. 15, 707-709.
Zachman, L., Barrett, M., Huisingh, R., Orman, J., & Blagden, C.(1991). Test of
Problem Solving-Adolescents, LinguiSystems, East Moline.
Zachman, L., Huisingh, R., Barrett, M., Orman, J., & LoGiudice, C.(1994). Test of
Problem Solving-Elementary, Revised, LinguiSystems, East Moline.

65

I
I

appendices

I

66

APPENDIX A
LETTER TO SPEECH-LANGUAGE PATHOLOGISTS

67

APPENDIX A
LETTER TO SPEECH-LANGUAGE PATHOLOGIST
Date
Name
Address
Dear
Brain tumors are the second most common form of pediatric cancer, affecting
between 1,500 and 2,000 children annually. Patients undergo extensive rehabilitation
after treatment including speech therapy, physical therapy, and occupational therapy. In
this research project, the main tumors researched are medulloblastoma tumors and brain
stem glioma tumors. A medulloblastoma tumor is one type of malignant brain tumor that
arises in the fourth ventricle and cerebellar vermis or the posterior fossa region of the
brain. Brain stem glioma tumors are tumors that arise along the midbrain, pons, or
medulla which are deep in the posterior portion of the brain.
My name is Emily Chambers and I am currently a senior at the University of
Mississippi studying Communicative Disorders. I am conducting this research project to
fulfill the graduation requirements for the Sally McDonnell-Barksdale Honors College. I
have chosen to research the role of speech-language pathology in the treatment of
pediatric brain stem glioma tumors and medulloblastoma tumors. This project will also
examine the incidence of speech/language disorders and swallowing disorders, in order to
see which type of disorder is more prevalent following treatment of a pediatric brain
tumor.
Attached to this letter is a survey that I would appreciate if you could take the
time to complete. This survey will not take more than ten minutes of your time and your
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answers will be kept confidential. When you finish the questionnaire, please mail it back
to the return address above in the enclosed self-addressed envelope. If you would like a
copy ot the results, please indicate at the bottom of the questionnaire and I will send them
to you at the given contact information.
This experiment has been read by The University of Mississippi’s Institutional
Review Board (IRB). The IRB has determined that this experiment follows the
obligations required by federal law and University policies. If you have any questions,
concerns or reports regarding your rights as a research subject, please contact the IRB at
(662)915-3929. Protected Health Information means any personal health information
that may identify you. The data in this experiment will include your experiences in
treating children with brain stem glioma tumors and medulloblastoma tumors. A
decision to take part in this research study means that you agree to the use of your
occupational information. This information will be used as described in this form. This
information will not be released for any reasons that do not concern this experiment. The
information collected will be kept until the experiment is finished. While this experiment
is ongoing you may not have access to the research information, but you may request it
after the research is finished.
Research on the speech, language, and swallowing disorders that may follow
pediatric brain tumors is very important and can help professionals gain a better
understanding of how to treat these patients. Thank you once again for taking time to
complete this survey.
Sincerely,
Dr. Carolyn Wiles Higdon
Ph. D, CCC-SLP, F-ASHA
Advisor

Emily Chambers
Undergraduate Honors Student
The University of Mississippi
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Fax;

May 9. 2008

Ms. Emily Chambers
2000 Lexington Pointe Drive. Apt. 13 C
Oxfora, MS 38655

Dr. Carolyn Higdon
Communication Sciences and Disorders
University, MS 3S677

Dear Ms. Chambers and Dr. Higdon:
This IS to inform you that your application to conduct research with human participants, Pediatric
Brain Tumors and Subsequent Motor Speech/Swallowing Disorders (Protocol No. 08-150) has
been approved as Exempt under 45 CFR 46.101(b)(2).
Please remember that ail of The University of Mississippi's human participant research activities,
regardless of v^hether the research is subject to federal regulations, must be guided by the ethical
principles m The Belmont Report: Ethical Principles and Guidelines for the Protection of Human
Subjects of Research.
It is especially important for you to keep these points in mind:
●

You must protect the rights and welfare of human research participants.

●

Any changes to your approved protocol must be reviewed and approved before initiating
those changes.

●

You must report promptly to the IRB any injuries or other unanticipated problems involving
risks to participants or others.

If you have any questions, please feel free to call me at (662) 915-7482.
Sincerely,

I.\
,

I. ■- i i

/

Diane W. Lindley
■ I
Coordinator, Institutional Review Board

- \ Gi'iut

Pitl'lr'
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APPENDIX C
ADDRESSES FOR SPEECH-LANGUAGE PATHOLOGISTS
Indicates Follow-up Letters
Indicates 2"^ mailing
Indicates 3*^ mailing
# Indicates Response Received
1. ALABAMA
A. University of South Alabama Children’s and Women’s Hospital *#
Karen Walker-Director of Therapy Services;
1700 Center St.
Mobile, AL 36604-3391
B. Children’s Hospital of Alabama #
Dept, of Pediatric Rehabilitation Medicine,
1600 7^ Avenue South, ACC Suite 406,
Birmingham, AL 35233
2. ALASKA
A. Children’s Hospital at Providence *#
3200 Providence Drive
Anchorage, AK 99508
B. Alaska Regional Hospital ***#
2801 DeBarrRoad
Anchorage, AK 99508
3. ARIZONA
A. Phoenix Children’s Hospital *#
1919 East Thomas Road
Phoenix, AZ 85016
B. Banner Children’s Hospital at Banner Desert Medical Center ***
1400 South Dobson Road
Mesa, AZ 85202
4. ARKANSAS
*
A. Arkansas Children’s Hospital
800 Marshall Street
Little Rock, AR 72202
B. University of Arkansas for Medical Sciences Medical Center ***#
4301 West Markham Street
Little Rock, AR 72205
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5. CALIFORNIA
A. Children’s Hospital Central California #
9300 Valley Children's Place
Madera, CA 93636-8762
B- Children’s Hospital Los Angeles
4650 Sunset Boulevard
Los Angeles, CA 90027
C. Alta Bates Summit Medical Center- Alta Bates Campus
2450 Ashby Avenue
Berkeley, CA 94705
6. COLORADO
A. Memorial Hospital for Children *
1400 E. Boulder St.
Colorado Springs, CO 80909
B. University of Colorado Hospital
12605 East la"* Avenue
Aurora, CO 80045
7. CONNECTICUT
A. Connecticut Children’s Medical Center #
Speech and Audiology
282 Washington Street
Suite 2F
Hartford, CT 06106
B. Yale-New Haven Children’s Hospital #
20 York Street
New Haven, CT 06510-3202
8. DELAWARE
A. The Alfred I. DuPont Hospital for Children *#
1600 Rockland Road
P.O. Box 269
Wilmington, DE 19899
B. Christiana Hospital ***#
4755 Ogletown-Stanton Road
Newark, DE 19718
9. FLORIDA
A. St. Joseph’s Children’s Hospital of Tampa #
3001 W. Dr. Martin Luther King Jr. Blvd.
Tampa, FL 33607
B. All Children’s Hospital
801 6**^ Street South
St. Petersburg, FL 33701
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10. GEORGIA
A. Children’s Healthcare of Atlanta at Scottish Rite #
1001 Johnson Ferry Road NE
Atlanta, GA 30342-1600
B. Athens Regional Medical Center ***#
1199 Prince Avenue
Athens, GA 30606
11. HAWAII
*
A. Shriners Hospital for Children (Honolulu)
1310 Punahou St.
Honolulu, HI 96826-1099
B. Kapi'olani Medical Center for Women & Children ***#
1319 Punahou St.
Honolulu, HI 96826
12. IDAHO
A. St. Luke’s Children’s Hospital *##
190 E. Bannock St.
Boise, ID 83712
B. Eastern Idaho Regional Medical Center ***#
3100 Channing Way
Idaho Falls, ID 83404
13. ILLINOIS
A. Children’s Memorial Hospital *#
2300 Children’s Plaza
Chicago, IL 60614-3363
B. Shriners Hospitals for Children (Chicago)#
2211 N. Oak Park Ave.
Chicago, IL 60707
C. Advocate Christ Medical Center/Advocate Hope Children’s Hosp.
4440 West 95"^ Street
Oak Lawn, IL 60453
D. Loyola Univ. Med. Center/Ronald McDonald Children’s Hospital **#
2160 South First Avenue
Maywood, IL 60153
E. Mercy Hospital
2525 South Michigan Avenue
Chicago, IL 60616-2477
F. Michael Reese Hospital and Medical Center
2929 S. Ellis Avenue
Chicago, IL 60616
G. Sinai’s Children’s Hospital
California Avenue at 15‘*^ Street
Chicago, IL 60608
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14. INDIANA
A. Peyton Manning Children’s Hospital at St. Vincent *#
2001 West 86th Street
Indianapolis, IN 46260
B. Community Hospital
901 MacArthur Boulevard
Munster, IN 46321
C. Dupont Hospital **#
2520 East Dupont Road
Fort Wayne, IN 46825
D. Home Hospital

I116N. le"* Street
Lafayette, IN 47904
E. Lutheran Hospital of Indiana
7950 West Jefferson Boulevard
Fort Wayne, IN 46804
15. IOWA
A. Blank Children’s Hospital *#
1200 Pleasant Street
Des Moines, lA 50309
B. Allen Hospital
1825 Logan Avenue
Waterloo, lA 50703
Attn: Dept, of Speech-Language Pathology Carey Degroote
C. Genesis Medical Center, Davenport
1227 East Rusholme Street
Davenport, lA 52803
Attn: Ron Bear
D. Mercy Medical Center **#
701 Tenth Street Southeast
Cedar Rapids, lA 52403
E. Mercy Medical Center- Des Moines **#
1111 Sixth Avenue
Des Moines, lA 50314
Attn: Director of Rehabilitation, Lynne Gamer
16. KANSAS
A. University of Kansas Medical Center *#
3901 Rainbow Boulevard
Kansas City, KS 66160
B. Overland Park Regional Medical Center **
10500 Quivira Road
Overland Park, KS 66215
Attn: Director of Rehabilitation, Janice Haip
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C. Via Christi Regional Medical Center- St. Francis Campus
929 North Saint Francis
Wichita, KS 67214
Attn: Director of Rehabilitation, Sue Willey
17. KENTUCKY
A. Kentucky Children’s Hospital
800 Rose St.

*

Lexington, KY 40536-0293
B. Jennie Stuart Medical Center **
320 West 18"^ Street
Hopkinsville, KY 42240-2400
C. King’s Daughters Medical Center
2201 Lexington Avenue
Ashland, KY41101
Attn: Dept, of Speech-Language Pathology, Kaci Norris
D. Pikeville Medical Center **
911 Bypass Road
Pikeville, KY 41501
18. LOUISIANA
A. Children’s Hospital(New Orleans)*#
200 Henry Clay Avenue
New Orleans, LA 70118
B. Baton Rouge General- Mid City
3600 Florida Boulevard
Baton Rouge, LA 70806
C. CHRISTUS Schumpert Saint Mary Place **
One Saint Mary Place
Shreveport, LA 71101
Attn: Dept, of Speech-Language Pathology, Stephanie Lynn
D. East Jefferson General Hospital
4200 Houma Boulevard
Metairie, LA 70006
19. MAINE
A. Barbara Bush Children’s Hospital *#
22 Bramhall Street
Portland, ME
B. Eastern Maine Medical Center **
489 State Street
Bangor, ME 04401
C. Central Maine Medical Center **
300 Main Street
Lewiston, ME 04240
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20. MARYLAND
A. Johns Hopkins Children’s Center *
600 North Wolfe Street
Baltimore, MD 21287
B. Anne Arundel Medical Center **
2001 Medical Parkway
Annapolis, MD 21401
Attn: Dept, of Speech-Language Pathology, Heather Langford
C. Franklin Square Hospital Center
9000 Franklin Square Drive
Baltimore, MD 21237
D. Frederick Memorial Hospital He*
400 West Seventh St.
Frederick, MD 21701
E. Johns Hopkins Bajrview Medical Center
4940 Eastern Avenue
Baltimore, MD 21224
F. St. Joseph Medical Center **#
7601 Osier Drive
Towson, MD 21204
21. MASSACHUSETTS
*
A. Children’s Hospital Boston
300 Longwood Avenue
Boston, MA 02115
B. Beth Israel Deaconess Medical Center **#
330 Brookline Avenue
Boston, MA 02215
C. Caritas Saint Elizabeth’s Medical Center **
736 Cambridge St.
Boston, MA 02135
D. Charlton Memorial Hospital
363 Highland Avenue
Fall River, MA 02720
E. Massachusetts General Hospital- Mass General Hospital for Children
55 Fruit Street
Boston, MA 02114
22. MICHIGAN
A. C.S. Mott Children’s Hospital #
1500 E. Medical Center Drive
Ann Arbor, MI 48109
B. Beaumont Hospital, Royal Oak **#
3601 West Thirteen Mile Rd.
Royal Oak, MI 48073
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c.

Harper University Hospital
3990 John R
Detroit, MI 48201
D. Hurley Medical Center **#
One Hurley Plaza
Flint, MI 48503
E. Marquette General Hospital **#
580 West College Ave.
Marquette, MI 49855
F. Beaumont Health Center **
Children’s Speech-Language Pathology
4949 Coolidge Hwy
Royal Oak, MI 48073
Attn: Dept, of Speech-Language Pathology, Kristine Rutkowski
23. MINNESOTA
A. Mayo Eugenio Litta Children’s Hospital *
1216 Second St. S.W.
Rochester, MN 55902
B. Abbott Northwestern Hospital
800 East 28''' St.
Minneapolis, MN 55407
C. Hennepin County Medical Center **#
701 Park Avenue
Minneapolis, MN 55415
Attn: Dept, of Speech-Language Pathology, Maxine Slobof
D. North Memorial Medical Center **
3300 Oakdale Avenue North
Robbinsdale, MN 55422
Attn: Dept, of Speech-Language Pathology, Amanda Myers-Kuitu
E. Saint Cloud Hospital **#
1406 Sixth Avenue North
Saint Cloud, MN 56303
24. MISSISSIPPI
*
A. Blair E. Batson Children’s Hospital
2500 North State St.
Jackson, MS 39216
B. Baptist Medical Center
1225 North State Street
Jackson, MS 39202
C. North Mississippi Medical Center He*
830 South Gloster St.
Tupelo, MS 38801
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D. Forrest General Hospital
6051 U.S. Highway 49
Hattiesburg, MS 39404
25. MISSOURI
A. Children’s Mercy Hospital *#
2401 Gilham Road
Kansas City, MO 64108
B. St. Louis Children’s Hospital *#
One Children's Place
St. Louis, MO 63110
C. Ranken Jordan *#
11365 Dorsett Road
Maryland Heights, MO 63043
D. Saint Francis Medical Center
211 Saint Francis Dr.
Cape Girardeau, MO 63703
E. Columbia Regional Hospital
404 Keene St.
Columbia, MO 65201
F. SSM Saint Mary’s Health Center
6420 Clayton Road
Richmond Heights, MO 63117
G. St. Luke’s Hospital
4401 Womall Road
Kansas City, MO 64111
26. MONTANA
A. Shodair Children’s Hospital *
2755 Colonial Drive
PO Box 5539
Helena, MT 59604
B. Billings Clinic Hospital
2800 10^*^ Avenue North
PO Box 37000
Billings, MT 59107-7000
27. NEBRASKA
A. Children’s Hospital Omaha *#
8200 Dodge St
Omaha, NE 68114
B. Bryan LGH Health System
1600 South 48'^ Street
Lincoln, NE 68506-1299
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28. NEVADA
*
A. Sunrise Children’s Hospital
3186 South Maryland Pkway
Las Vegas, NV 89109
B. North Vista Hospital
1409 E. Lake Mead Blvd.
North Las Vegas, NV 89030
29. NEW HAMPSHIRE
A. Children’s Hospital at Dartmouth
789 Central Avenue
Dover, NH 03820

*

B. Exeter Hospital
5 Alumni Drive
Exeter, NH 03833
30. NEW JERSEY
A. The Joseph M. Sanzari Children’s Hospital *
30 Prospect Ave
Hackensack, NJ 07601
B. Children’s Hospital of New Jersey at Newark Beth Israel Med. Center
201 Lyons Ave., Suite L5
Newark, NJ 07112
31. NEW MEXICO
A. University of New Mexico Children’s Hospital *
2211 Lomas Blvd. N.E.
3rd Floor of UNM Hospital
Albuquerque, NM 87131
32. NEW YORK
A. Elizabeth Seton Pediatric Center *#
590 Avenue of the Americas
New York, NY 10011
B. Morgan Stanley Children’s Hospital of New York (Presbyterian) *
3959 Broadway
New York, NY 10032
33. NORTH CAROLINA
A. Levine Children’s Hospital
1000 Blythe Blvd
Charlotte, NC 28203

*
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B. Pitt County Memorial Hospital ***#
2100 Stantonsburg Rd.
Greenville, NC 27835
34. NORTH DAKOTA
A. MeritCare Children’s Hospital *##
P.O. Box M.C.
Fargo, ND 58122
B. Linton Hospital
518 North Broadway
Linton, ND 58552
35. OHIO
A. Children’s Hospital Medical Center of Akron *#
1 Perkins Square
Akron, OH 44308
B. Cincinnati Children’s Hospital Medical Center #
3333 Burnet Avenue,
Cincinnati, OH 45229-3039
C. Clevelemd Clinic Children’s Hospital for Rehabilitation *#
2801 Martin Luther King Jr Dr
Cleveland, OH 44104
D. Nationwide Children’s Hospital #
700 Children's Drive
Columbus, OH 43205
36. OKLAHOMA
A. Children’s Hospital at OU Medical Center *#
1200 Everett Drive
Oklahoma City, OK 73104
B. The Children’s Hospital at Saint Francis ***#
6161 South Yale Avenue
Tulsa, OK 74136
37. OREGON
A. Doembecher Children’s Hospital *
15220 NW Laidlaw, Suite 100
Portland, OR 97229
B. Legacy Emanuel Children’s Hospital *#
2801 N Gantenbein Avenue
Portland, OR 97227
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38. PENNSYLVANIA
A. Lehigh Valley Hospital *#
P.O. Box 689
Allentown, PA 18105-1556
*
B. St. Christopher’s Hospital for Children
3601 A Street
Philadelphia, PA, 19134
C. Children’s Hospital of Philadelphia *
34th Street and Civic Center Boulevard
Philadelphia, PA 19104-4399
39. RHODE ISLAND
A. Hasbro Children’s Hospital at Rhode Island Hospital *#
167 Point Street
Providence, RI 02903
B. Kent Hospital
455 Toll Gate Rd.
Warwick, RI 02886
40. SOUTH CAROLINA
*
A. MUSC Children’s Hospital
171 Ashley Ave.
Charleston, SC 29425
*
B. Shriners Hospital for Children
950 W Paris Rd
Greenville, SC 29605
41. SOUTH DAKOTA
A. Sanford Children’s Hospital *#
1305 West 18th Street
Sioux Falls, SD 57117-5039
B. St. Michael’s Hospital
410 West 16* Ave.
Tyndall, SD 57066
42. TENNESSEE
A. Le Bonheur Children’s Medical Center #
50 N. Dunlap Street,
Memphis, TN 38103
B. St. Jude Children’s Research Hospital *#
262 Danny Thomas Place
Memphis, TN 38105
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43. TEXAS
A. Children’s Medical Center of Dallas *
1935 Medical District Dr
Dallas, TX 75235
B. Children’s Memorial Hermann Hospital *
7737 Southwest Freeway, Suite 200
Houston, TX 77074
C. Methodist Children’s Hospital of South Texas *
7700 Floyd Curl Drive
San Antonio ,TX 78229
44. UTAH
A. Primary Children’s Medical Center *#
100 North Medical Drive
Salt Lake City, UT 84113
B. Shriners Hospital for Children (Salt Lake City) *
1275 Fairfax Rd
Salt Lake City, UT 84103
45. VERMONT
A. Vermont Children’s Hospital
111 Colchester Ave
Burlington, VT 05401
B. Mt. Ascutney Hospital
289 County Road
Windsor, VT 05089
46. VIRGINIA
A. Children’s Hospital of the King’s Daughters #
601 Children's Lane
Norfolk, VA 23507
B. VCU Health System Children’s Medical Center *
1250 East Marshall Street,
Richmond, VA 23298
C. Children’s Hospital Richmond *
2924 Brook Road
Richmond, VA 23220-1298
D. University of Virginia Children’s Hospital #
Pediatrics
PO Box 800386
Chai'lottesville, VA 22908
47. WASHINGTON
A. Mary Bridge Children’s Hospital and Health Center
311 S LSt
Tacoma, WA 98405
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B. Children’s Hospital and Regional Medical Center
4800 Sand Point Way NE
Seattle, WA 98105
48. WASHINGTON D.C.
A. Children’s National Medical Center #
111 Michigan Avenue,
NW Washington, DC 20010
49. WEST VIRGINIA
A. WVU Children’s Hospital #
PO Box 8200
6th Floor, Ruby
Morgantown , WV 26506
B. Cabell Huntington Hospital
1340 Hal Greer Blvd.
Huntington, WV 25701
50. WISCONSIN
A. Children’s Hospital of Wisconsin #
PO Box 1997
Milwaukee, WI 53201-1997
B. University of Wisconsin Hospital
600 Highland Avenue
Madison, WI 53792
51. WYOMING
A. Memorial Hospital of Carbon County
2221 W.Elm Street
Rawlins, WY 82301
B. North Big Horn Hospital *#
1115 Lane 12
Lovell, WY 82431
*Indicates Follow-up Letters
**Indicates 2^^ mailing
***Indicates 3*^^^ mailing
# Indicates Response Received
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APPENDIX D
SURVEY
1. How long have you been practicing in the field of speech-language
pathology?
a. 0-5 years
b. 6-10 years
c. 11-15 years
d. 15-f-years
2. How many years have you worked as a speech-language pathologist(SLP)
with children with brain tumors?
a. 0-5 years
b. 6-10 years
c. 11-15 years
d. 15 -h years
3. What type of pediatric brain tumors have you evaluated and/or treated? Please
specify by each type whether you have evaluated, treated, or both,
a. Brain Stem Glioma
b. Medulloblastoma
c. Neither
d. Both
4. In your experiences with these patients, what types of treatments have the
children received?
a. Chemotherapy
b. Radiation
c. Surgery
d. Both a. and b.
e. Both b. and c.
f. Both a. and c.
g. All of the above
h. None of the above
5. What types of residual communication effects occur in children with brain
tumors?
a. Motor Speech Deficits
b. Mutism
c. Cognition Deficits
d. Language Processing Problems
e. Swallowing Disorders
f. Other (please specify)
6. How many of your patients exhibit speech or swallowing problems after
treatment of their brain tumors?(An estimate is fine.)
7. How long do these problems persist?
a. Less than one week after treatment
b. 1 week-1 month
c. 1 month-3 months
d. 3-6 months
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e. > than 6 months
8. How often do you treat patients with pediatric brain tumors?
a. < than 1 hour a week
b. 1-2 hours a week
c. 2-3 hours a week
d. 3-4 hours a week
e. 4-5 hours a week
f. > than 5 hours a week
9. What types of follow up treatment do you perform for patients with pediatric
brain tumors?
a.
b.
c.
d.
e.

Treat for as long as problems persist
Refer patients to Outpatient SLP services
Work with educational (school) team to transition
Re-evaluation periodically
Other (please explain)

10. What is the one most important point for SLPs to realize in working with
children with tumors?
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APPENDIX E
SURVEY NARRATIVES
Question 6
I A) 50%
IB) 85%
2A) 80% of patients
2B) NA (we do not treat pediatrics)
3A) -75%
5A) 75%
7A) Difficult question to answer because there may be patients admitted with these
tumors that do not need all services. Therefore we do not know they exist. Therefore
any patient that is referred to us usually has a speech or swallowing problem, which is
why they are referred.
7B) Most
8A) 100%
9A) As I am inpatient, I don’t see kids after their treatment but more so during
treatment but, I would say at least 90%
10A) 100%
lOB) All that have been here
IIB) -50-60%
12A) 50%
12Ab) 100% The doctors would not order speech therapy unless there was a problem
in these areas.
13A) I may not get consulted on all, but 95-100% of the ones for whom I receive a
consult for
13D) 75%
14A) 1/1
90

15A) 50%
15E) 0
16A) -25%
18A) 75-80%
19A) 1 year
22A) 25%
22B) NA (we do not see many children with brain tumors at this site)
22D) Unable to give estimate, most have treatment before coming to speech
23C) Of the small number, all have exhibited speech and swallowing problems. My
experience is most pediatric patients are treated at another facility where follow-up
services are provided.
25A) All, that’s why speech consulted
25B) -85-95%
25C) 1
27A) 80% speech/language
33B) 1/1
34A) 30%
34Ab) 25%
35A) 70%
35B) Depends on location of tumor/treatment course selected
35C) 50%
35D) 75%
36A) 100% (otherwise I would not receive a consult)
36B) 100%
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37B) 100% The severity of the problem varies mild-severe
39A) With posterior fossa tumors -80% swallowing -50% mutism
41 A) NA (we do not treat these pts.)
42A) 50%
42B) -70-75%
44A) 70-85%(we only get referrals on those pts who exhibit cognitive or swallow
deficits)
46A) 75%
46D) -80%
48A) 100% (this is why we are referred)
49A) -80%
50A) 90%
Question 9e
5A) MBSS as needed
8A) I work in a rehab setting so we treat the patient as long as problem persists as
well as transition the child back to school if possible.
9A) Cognitive evaluations
lOA) Inpatient rehabilitation
12Ab) Several patients have received outpatient Modified Barium Swallow studies
post d/c
13A) If residual deficits, typically transfer to rehab hospital
15E) Unknown
33B) Feeding/speech issues
34Ab) We have a Coordinated Treatment Center that conducts a Peds Acquired BI
Clinic monthly.
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42A) We are an acute facility. We do a pre and post-operative cognitive and
communication evaluation. If any post-op deficits are identified we treat until
discharged to outpatient therapy or St. Jude.
48A) Transition from inpatient to outpatient. Tx if I have an opening
Question 10
1 A) These children have sensory issues secondary to needles and tubes inserted into
their bodies.
2A) Deficits are individualized and will vary greatly from child to child.
3A) Swallowing Problems are very severe due to location of brain injury.
4B) We don’t have the experience to comment on this.
5A) Thorough medical chart review and safety first, with respect to eating and
drinking. Ongoing family education.
7A) Every patient with a brain tumor is different.
7B) Prognosis and appropriate level of intervention.
8A) It is important to realize that we are treating speech-language deficits and
swallowing dysfunction; however, “quality of life” is an integral piece. We need to
help our families cope at times secondary to the difficult/devastation
recommendations we are making at times.
lOA) Brainstem tumors have high risk of aspiration- need swallowing checked out
by SLP.
lOB) The interpersonal (emotional journey) of possibly losing these kids. Knowing
what you can fix and what you can’t.
1 IB) Allow rest periods and avoid over-stimulation.
12A) Teach the parents.
12Ab) Decreasing environmental stimulation as needed particularly immediately
post op. Treat mutism like apraxia and associated motor dysfunction. I personally
think that craniosacral therapy has been helpful in treating the apraxic-like symptoms
post posterior fossa tumors unfortunately our medically staff does not recognize its
value.
13A) Deficits can be affected by where they are in treatment.
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13D) Families need to be involved in the entire process. Depending on where the
child is with treatment, they can have varying degrees of dysphagia and cognitive
deficits day to day.
14A) Treat each patient with an individualized treatment plan because each child will
present differently at different points of the “recovery” process.
14C) We do not see children with brain tumors at our hospital. So sorry!
15A) That the size, location, and types of medical treatment make EACH one
different!
16A) Neuroplasticity
19A) Patient/Family education and making appropriate discharge plans from hospital
to outpatient or home health.
22A) Can’t assume outcome based on tumor location/type like in adults and you
must compare functional status to premorbid function rather than just look at standard
scores.
22D) Have seen slow, steady progress.
22E) I believe it would be target functional skills with direct application to a child’s
daily living skills and environment, school performance, social-communication and
peer relationships etc. Ask- what skills make the biggest impact or cause the most
problems or consequences? Start there.
23C) Sequelae of radiation treatment, anticipate exacerbation of symptoms or
recurrence of tumor. Treatment for compensatory approaches.
23E) Psychological/mental health of these children.
25A) It’s a family/team approach.
25B) Treat the issues that arise, not what you think the deficit(tumor type or
placement) might be. That is good knowledge to start your assessment, but treat what
you see.
27A) The child’s awareness of their deficits. Recognition of deficits in word finding,
processing and memory.
32A) Limited experience precludes an opinion at this time.
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33B) I have only had 1 patient with brain tumor at this facility in 4 years that was
referred with feeding/speech issues. She was 13 m and didn’t survive 3 months s/p

dx.
34A) Each child will present differently regardless of the type of tumor. Education
for future difficulties is so important, especially in the really little kids.
34Ab) Outcomes can vary and we need to focus on the patient’s current functional
needs knowing they will chg. as pt. grows and develops. Adaptations need to be
made to respond to these changes.
35A) A thorough assessment in all parameters is imperative, as a multitude of
manifestations can potentially be expected.
35B) often children with brain tumor dx have a poor prognosis however you can
work to improve their quality of life while they are completing their treatment
protocol.
35C) They may have difficulty tolerating acute rehab, irritability and need to focus of
function initially/family education.
35D) Understanding different symptoms that can be observed pre or post-surgery
(e.g. posterior fossa syndrome)
36A) These children have been through a lot. Keep it fun and let them have fun and

be kids!
36B) Sometimes treatment/therapy can be more for family benefit than actual patient
progress and is palliative in nature.
37B) After a tumor resection, remember to think about what these kids have been
through- there is a high level of fmstration when these kids can’t communicate
verbally- reassure them you’ll be working together to find a way.
42A) The children can be quite resilient and in a majority of cases, the children do
not need speech services. Patients with brainstem gliomas typically demonstrate
issues with oral dysphagia early on demonstrating both oropharyngeal dysphagia as
the patient progresses. Posterior fossa syndrome seen with medulloblastoma patients
affecting both PO feeding skills and communication skills. Cases can last as long as
6 months with a few documented cases up to 1 year. Patients have poor interaction
with their environment, but will recall events once posterior fossa syndrome has
resolved.
42B) Radiation has long-term effects that can result in changes in language/cognition
for many years after treatment has been completed. Therefore, all children who
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receive radiation should be closely monitored as they are at high risk for
language/cognitive deficits.
44A) The patient continually changes and requires reassessment.
46A) They need constant reassessment and reevaluation because their needs, skills,
and abilities are constantly changing.
46D) Their deficits can be very different from those patients with acquired brain
injuries such as TBI, CHI, stroke, etc. There is also a very different grieving process
for parents, as these tumors may return.
48A) Each child presents differently and family input is vital!
50A) Each child is VERY different, even if their tumor is in the same place.
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MAP OF SLPS’ RESPONSES BY STATE
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APPENDIX G
LIST OF ABBREVIATIONS

CNS

central nervous system

ADL

activities of daily living

CT

computed tomography

CSF

cerebrospinal fluid

MRI

magnetic resonance imaging

MRA

magnetic resonance angiography

MRS

magnetic resonance spectroscopy

EBRT

external beam radiation therapy

IRT

internal radiation therapy

IQ

intelligence quotient

CBTRUS

Central Brain Tumor Registry of the United States

CBCL

Child Behavior Check List

CMS

cerebellar mutism syndrome

V/PPSI-R

Wechsler Preschool and Primary Scales ofIntelligence

DAS

Differential Abilities Scale

VMI

Beery Visual Motor Integration

EOWPVT-R

Gardner Expressive One-Word Picture Vocabulary
Test

CELF-3

Clinical Evaluation ofLanguage Fundamentals-3'^^ Ed.

CELF-P

Clinical Evaluation ofLanguage Fundamentals-
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Preschool
PPVT-III

Peabody Picture Vocabulary Test-Third Edition

HPNT

Hundred Pictures Naming Test

TOPS-Elementary

Test ofProblem Solving-Elementary, Revised

TOPS-Adolescent

Test ofProblem Solving-Adolescent

TOWK

Test of Word Knowledge

TLC-E

Test of Language Competence-Expanded Edition

QUIL

Queensland University Inventory ofLiteracy

TOPA

Test ofPhonological Awareness

VABS

Vineland Adaptive Behavior Scales

RAVLT

Rey Auditory Verbal Learning Test
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APPENDIX H
LIST OF DEFINITIONS
Abducens Nerve- a small motor nerve supplying the lateral rectus muscle of the eye
(Stedman \s Medical Dictionary)
Apathy- Indifference; absence of interest in the environment. Often one of the
earliest signs of cerebral disease.(Stedman's Medical Dictionary)
Apraxia- I. A disorder of voluntary movement, consisting of impairment in the
performance of skilled or purposeful movements, notwithstanding the preservation of
comprehension, muscular power, sensibility, and coordination in general; due to
acquired cerebral disease. 2. A psychomotor defect in which the proper use of an
object cannot be carried out although the object can be named and its uses described.
iStedman's Medical Dictionary)
Astrocyte- cells found between blood vessels and neurons (Greenberg, 1997)
Astrocytoma- central nervous system tumors derived from astrocytes (Greenberg,
1997)
Ataxia- An inability to coordinate muscle activity during voluntary movement; most
often due to disorders of the cerebellum or the posterior columns of the spinal cord;
may involve the limbs, head, or tiiink. {Stedman's Medical Dictionary)
Basal Forebrain- The anterior primitive cerebral vesicle and the most rostral of the
three primary brain vesicles of the embryonic neural tube; it subdivides to form the
diencephalon and telencephalon. {Stedman's Medical Dictionary)
Brain edema- brain swelling due to increased volume of the extravascular
compartment from the uptake of water in the neuropile and white matter. {Stedman 's
Medical Dictionary)
Brain Stem- Originally, the entire unpaired subdivision of the brain, composed of(in
anterior sequence) the rhombencephalon, mesencephalon, and diecephalon as
distinguished from the brain's only paired subdivision, the telencephalon. More
recently, the term’s connotation has undergone several arbitrary modifications: some
use it to denote no more than rhombencephalon plus mesencephalon, distinguishing
that complex from the prosencephalon (diencephalon plus telencephalon); others
restrict it even further to refer exclusively to the rhombencephalon. From both
developmental and architectural viewpoints, the original interpretation seems
preferable.(Stedman's Medical Dictionary)
Calcification- 1. Deposition of lime or other insoluble calcium salts. 2. A process in
which tissue or noncellular material in the body becomes hardened as the result of
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precipitates or larger deposits of insoluble salts of calcium (and also magnesium),
especially calcium carbonate and phosphate (hydroxyapatite) normally occurring only
in the formation
bone and teeth. {Steelman's Medical Dictionary)
Cerebellar Muti.sm- transient and not uncommon complication following surgical
resection of posterior fossa tumors.(Rekate et al., 1985)
Cerebellar Vermis- the narrow middle zone between the two hemispheres of the
cerebellum: the portion projecting above the level of the hemispheres on the upper
surface is called the superior vermis; the lower portion, sunken between the two
hemispheres and forming the floor of the vallecula, is the inferior vermis.{Stedmans
Medical Dictionary)
Cyst- An abnormal sac containing gas. fluid, or a semisolid material, with a
membranous lining. {Stcdnian's Medical Dictionary)
Diencephalon- The caudal part of the prosencephalon composed of the epithalamus,
thalamus, and hypothalamus. {Stednian s Medical Dictionary)
Diffuse Intrinsic Brain Stem Glioma- a brain stem glioma spread out entirely in one
part of the brain. {Stednian's Medical Dictionary)
Dysarthria- A disturbance of speech due to emotional stress, to brain injury, or to
paralysis, incoordination, or spasticity of the muscles used for speaking.{Stedmans
Medical Dictionary')
Dysphonia- phonation disorder characterized by hypemasal and/or breathy voice
quality (Goncalves et. al., 2006)
Ependymal cells- cells that line the ventricles within the brain and center of the
spinal cord (Capodano, 2001)
Ependymoma- type of glioma tumor derived from ependymal cells (Capodano,
2001)
Executive function issues- including planning and sequencing (Levisohn et. al,
2000)
Facial Nerve Palsy- paralysis of facial nerve {Stedman's Medical Dictionary)
Focal Lesion- pathologic change in tissue relating to a localized area. {Stedmans
Medical Dictionary)
Fornix- The compact, white fiber bundle by which the hippocampus of each cerebral
hemisphere projects to the contralateral hippocampus and to the septum, anterior
nucleus of the thalamus, and mamillary body. {Stednian's Medical Dictionary)
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Hemiparesis- Weakness affeeting one side of the body.{Stedmans Medical
Dictionary)
High-grade tumors- grow rapidly and can easily spread through the brain, require
very intensive therapy (Disease Information, Astrocytoma/Glioma, n. d.)
Histology- The science concerned with the minute stmeture of cells, tissues, and
organs in relation to their function. {^Stedman s Medical Dictionary)
Hydrocephalus- A condition maiked by an excessive accumulation of cerebrospinal
Huid resulting in dilation of the eerebral ventricles and raised intracranial pressure;
may also result in enlargement of the cranium and atrophy of the brain.{Stedmans
Medical Dictionary)
Hypokinesis- Diminished or slow movement.{Stedman's Medical Dictionary)
Hypothalamus- The ventral and medial region of the diencephalon forming the walls
of the ventral half of the third ventricle prominently involved in the functions of the
autonomic (visceral motor) nervous system and, through its vascular link with the
anterior lobe of the hypophysis, in endocrine mechanisms; it also appears to play a
role in neural mechanisms underlying moods and motivational states. {Stedman's
Medical Dictionary)
Language processing problems- primarily in the areas of expressive and receptive
syntax, vocabulary, word fluency and literacy(Hudson and Murdoch, 1992)
Low-grade tumors- more localized tumors that grow slowly over a long period of
time (Disease Information, Astrocytoma/Glioma, n. d.)
Medulla- the most caudal subdivision of the brainstem, immediately continuous with
the spinal cord, extending from the lower border of the decussation of the pyramid to
the pons. {Stednum's Medical Dictionary)
Medulloblastoma- tumor found in the cerebellum (Bailey and Cushing, 1925)
Memory Disorder- ability to recall information (Spiegler, et. al., 2004)
Motor Speech Disorder- A disorder due to an inability to accurately produce speech
sound or phonemes due to muscle weakness/incoordination or difficulty in voluntary
muscle movement.{Stedman 's Medical Dictionary)
Mutism- the state of being silent and the organic or functional absence of the faculty
of speech {Stedman's Medical Dictionary)
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Neuroblastoma- A malignant neoplasm characterized by immature, only slightly
dilTcrcntiatcd ncr\ e cells of embryonic type, Le., neuroblasts.{Stedman'sMedical
Dictionary)
Optic Chiasm- a Hattened quadrangular body in front of the tuber cinereum and
infundibulum, the point of crossing or decussation of tlie axons of the optic nerves;
axons from the nasal retina cross to the opposite side while axons from the temporal
retina run directly caudal without crossing, some pass transversely on the posterior
surface betw een the two optic tracts and others pass transversely on the anterior
surface betw een the two optic nerves. {Stedman's Medical Dictionary^
Osteosarcoma- the most common and malignant of bone sarcomas, which arises
from bone-forming cells and affects chiefly the ends of long bones. {Stedmaivs
Medical Dictionary)
Pons- that part of the brainstem between the medulla oblongata caudally and the
mesencephalon rostrally, composed of the basilar part of pons and the tegmentum of
pons. {Stcdffian 's Medical Dictionary)
Pragmatic issues- rules of language governing how language is used for social
purposes(K. L. Pence & L. M. Justice, 2008)
Radiochemotherapy- radiation given during the first cycle of induction
chemotherapy with high-energy photon beams either by lateral opposed fields with
the child in the supine position or by two lateral and a posterior field with the child in
the prone position (Benesch et al, 2001)
Thalamus- large, ovoid mass of gray matter that forms the larger dorsal subdivision
of the diencephalon. {Stednuin's Medical Dictionary)
Word finding difficulties- vocabulary (Docking et al, 2005)
Velum- 1. Any serous membrane or membranous envelope or covering 2. Any
structure resembling a veil or curtain {Stedman's Medical Dictionary)

106

L

APPENDIX I
DIAGRAMS OF THE BRAIN

107

APPENDIX I
DIAGRAMS OF THE BRAIN

CSRffQfUU.

MJkTCn

vSNTRaCUS
AMO

ARACMMCMO

c*«cx»saEo

P--A MAT«n

PVCAUSCO

sua>.« A-o^NJOto
'.PACE

cc.nro£LLun

* f MTOmuA*
CK»TCR30D

roaSA

f-C RFEmAg.
AQUEDUCT

.tj-rt.vnjsi

Figure 9. Mcni

es and Ventricles of the Brain

PARIETAL LOBE
INTELLECT
THOUGHT
HEASONSNQ
MCMOnV
THOUGHT

LEFT^ SPEECH.

HEASONINO
BEHAVlOB
MEMORY

^

hsoTon & scNsonv
EUNCTtONfS*
BEHAYtOR
MEMORY
hearing &
VISION PATHWAYS
EMOTION

RSGMT^ ABSTRACT
CONCEPTS*
VISION

OCaPITAL
LOBE

CEREBELLUM

TEMPORAL
LOBE

BALANCE
CC-OnOINATtON

* EOR RIGHT HANDED
INDIVTDUALS

Figure 10. Functions of the Cerebral Hemispheres

108

L

OPTtC
CHIASM

OPTK mACT

FROHTAL
LOBE
CEnCBfLLUM
,1

OCCIPITAL
LOBE

MEDULLA
POMS

OLFACTORY BUL8

temporal lobe

I'i^urc 11. Vi-''' Iro.nthcBoUoniot'he Brain

CORPUS callosum
SKULL
V

DURA MATER
ARACHMOlO
—r SUBARACHNOID
' SPACE

P.NEAL
).

PIA MATER

tentorium ●
CHORO© PLetUS
UTERAL VENTROLi
PITUITARY OLAW)

CEREBELLUM

SPNENO© SINUS
* I

CHOROID PLEXUS
INTERVENTRICULAR FORAMEN
jOP MONRO)

rOURTH VENTRICLE

\
CENTRAL CANAL
OF SPINAL COHO
SUBARACHNOID SPACE
OF SPINAL CORO
5PINAL CORO

1

Figure 12. Lateral View of the Brain and Spinal Cord

m

liC Nl

/
StPTAL
AREA

m iiMAi ^.t

CiNGl^LATE

CORTFX

HYPOTHALAina
CORPUS
CALLOSUM ^

I OLFACTORY
J 8UL8

THAI AMUS «

(_ OPTW
V HtRVC
a

\
-LPPOCAMPI

SELLA
TURCICA

CFRFBELLUM
PITUITARY GLANO

MiOORAlN

MEDULLA
OBLONGATA

RtTiCUL AR
> ORMAT lOTS

- -

iPTNAL
CORD

DRAIN STt M
Widbrairt
Paina
Me<JuUo Oaiongalo
R«!»Colaf Foffnotion

UM81C SYSTEM;
Cingulato CoTtu
Sogtti Aroa

/

Hipp«CBnT(M

Fif^iirc 13. Cross-section of the Hoad

FRONTAL lobe
OP CEREBRUM

OPTIC
CHIASM

TFDAPORAL LOBE

CEREBELLUM

SPINAL CORO

^ SMELL
2 OPTIC
3 EVE MOVEMENT
4 EYE MOVEMENT
5 facial SENSATTOH
0 EYE MOVEMENT
7 FACE MOVEMENT
a HEAR1NO A BALANCE

0 taste
10 INVCHAINTARY MU3C1E8
Sto«n*cltt
Ttirodt. ChMt.
InUMKlmM)
t< NEa(A^B)BACX
VFH.UNTARV ifUSCLM
12 TONGUE

Figure 14. Cranial Nerves

110

SMn

Epidural Spaca

Dura

SulMrsctmokl Spscd

Modulla (Spinal Cord)

^
«

/

t

* 5

r

Uo

»
Spiral Nerv«

^ * a
?6

Borve
(Vortebra)

0
a 6

Narva Root

Figure 15. Cross-section of Vertebra and Spinal Cord
CERUICflL NERUES
~— Heaa and Neck
Diapnram
Deltoids, Biceps
liirist EHtenders
Triceps
Hand

<>
5

lORRaC NERUES

'A

Chest Muscles

df
;"ii

RDdo minai

Muscles
SRCRRL NERUES

Leg Muscles
SRCRRL NERUES
BOLuel, B:ladder

sexual Function

Figure 16. Spinal Cord and Nerve Roots

III

VITA
Emily Kathryn Chambers is a senior in the Department of Communication
Sciences and Disorders at the University of Mississippi. She will receive a Bachelor
of Arts degree in Communication Sciences and Disorders from the University of
Mississippi in May 2009 and graduate Magna Cum Laude. Emily is a member of Phi
Kappa Phi, Gamma Bela Phi, Eta Sigma Phi, Sigma Alpha Lambda, Alpha Lambda
Delta, and serves as membership chair of Mortar Board. She has been on either the
Chancellor's Honor Roll or the Dean's List each of her semesters at the University of
Mississippi. This project was presented in poster format at the 2008 American
Speech Language Hearing Association(ASHA)Convention in Chicago, Illinois.
This project was also accepted to the 2009 International Otolaryngology Conference
in Brazil.

112

